STRUCTURAL AND FUNCTIONAL STUDIES OF SALMONELLA TYPHIMURIUM EFFECTORS GTGE AND SPVB by Xu, Caishuang 1989-
  
 
STRUCTURAL AND FUNCTIONAL STUDIES OF SALMONELLA TYPHIMURIUM 
EFFECTORS GTGE AND SPVB 
 
 
 
 
A Thesis Submitted to the College of 
Graduate Studies and Research 
In Partial Fulfillment of the Requirements 
For the Degree of Master of Science 
In the Department of Biochemistry 
University of Saskatchewan 
Saskatoon 
 
By 
 
CAISHUANG XU 
 
 
 
 
 
 Copyright Caishuang Xu, November, 2015. All rights reserved. 
 i 
 
 
 
Permission to Use 
 
In presenting this thesis in partial fulfillment of the requirements for a Postgraduate 
degree from the University of Saskatchewan, I agree that the Libraries of this University may 
make it freely available for inspection.  I further agree that permission for copying of this thesis 
in any manner, in whole or in part, for scholarly purposes may be granted by the professor or 
professors who supervised my thesis work or, in their absence, by the Head of the Department or 
the Dean of the College in which my thesis work was done.  It is understood that any copying or 
publication or use of this thesis or parts thereof for financial gain shall not be allowed without 
my written permission.  It is also understood that due recognition shall be given to me and to the 
University of Saskatchewan in any scholarly use which may be made of any material in my thesis. 
Requests for permission to copy or to make other use of material in this thesis in whole 
or part should be addressed to: 
 
 
 Head of the Department of Biochemistry 
 University of Saskatchewan 
 Saskatoon, Saskatchewan, S7N 5E5 
 
 ii 
 
ABSTRACT 
 
Salmonella is a genus of Gram-negative bacteria, which is a major cause of foodborne 
disease.  To create a safe intracellular environment for the pathogen within the host cells, 
Salmonella secretes a large number of effectors into the host cytosol.  My research concentrates 
on a structural and functional characterization of two Salmonella effectors, GtgE and SpvB.  GtgE 
is a cysteine protease that specifically cleaves closely related GTPases, Rab29, Rab32 and Rab38.  
The full-length GtgE and several truncated constructs were cloned, expressed and purified.  
Extensive crystallization trials were performed with these constructs.  In addition, several 
crystallization rescue strategies have been employed, including introducing entropy-reducing 
surface mutations, chemical modification to the protein surface, and co-crystallization of inactive 
GtgE variants with substrate peptide.  Despite these extensive efforts, no crystals were obtained.  
However, new information about GtgE was discovered such as low protease activity in vitro 
against GST-Rab32 and identification of the N-terminal ~30 residues of GtgE as required for the 
full function.  
SpvB is a mono-ADP-ribosyltransferase that modifies G-actin.  SpvB is composed of two 
structural domains.  The C-terminal domain of SpvB (SpvB-C) possesses the mono-ADP-
ribosyltransferase activity and its structure has been determined.  This study provides the first 
structural determination of the N-terminal domain of SpvB (SpvB-N) at 2.4 Å resolution.  This 
domain is made primarily of β-strands and shows similarity to the N-terminal segment of YenB, 
an ABC toxin component.  A long groove on the protein surface suggests that it functions as a 
recognition domain.  The hypothesis that SpvB-N guides the localization of SpvB and targets the 
protein to actin was tested, but a co-immunoprecipitation assay excluded strong interaction 
between SpvB-N and actin.  Moreover, SpvB-N expressed as a GFP fusion localized to the 
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nucleus while SpvB and SpvB-C localized to the cytosol.  I have shown further that SpvB-C was 
sufficient to disrupt the actin cytoskeleton and induce cell apoptosis.  The similarity of SpvB-N 
to YenB prompted us to investigate its cytotoxicity but only a marginal effect on the host cells 
was noted.  Experiments to study the function of the SpvB-N were able to exclude some 
possibilities and narrowed down the spectrum of potential functions.   
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1. Introduction 
1.1 Salmonella infection 
Salmonella is a genus of Gram-negative bacteria, which causes diseases ranging from 
gastroenteritis to typhoid fever in humans (Ho et al., 2002).  The major transmission pathway of 
Salmonella in humans is through the consumption of contaminated food or water.  Salmonella 
infection is the second most frequently reported foodborne disease and is relatively common in 
Canada (Favrin et al., 2003).  According to the Public Health Agency of Canada about 4 million 
Canadians suffer from food-related illnesses each year.  Salmonella infection is also a global 
burden.  It was reported that ~95 million cases of gastroenteritis occur each year due to 
Salmonella poisoning and 80 million of these are foodborne (Majowicz et al., 2010).  The 
systemic disease typhoid fever affects yearly an estimated 20 million people worldwide and 
causes ~200,000 deaths (Crump et al., 2004; Crump and Mintz, 2010).  Salmonella species are 
intracellular pathogens (Jantsch et al., 2011).  Antibiotic therapy is commonly used for curing 
Salmonella infection.  However, bacteria develop different strategies to survive antibiotic 
treatment.  The bacterial resistance challenges the treatments for bacterial infection.  As a result, 
more and more research has been directed to address these pathogenic diseases.   
1.2 Salmonella nomenclature 
The genus Salmonella comprises two species, Salmonella bongori (S. bongori) and 
Salmonella enterica (S. enterica) (Fig. 1-1).  The S. enterica has six subspecies, namely: enterica 
(I), salamae (II), ariozonae (III), diarizonae (IV), houtenae (V) and indica (VI) (Reeves et al., 
1989).  The subspecie S. enterica (I) has more than 2400 serovars (Faucher et al., 2005).  The 
serovars are classified into two groups according to the syndromes they cause, non-typhoidal 
serovars and typhoidal serovars.  Non-typhoidal serovars, like S. enterica serovars Typhimurium 
and Enteritidis, are major causes of gastroenteritis (Spanò and Galán, 2012).  These serovars 
account for ~65% of the most frequently isolated serotypes (Ishola and Holt, 2008).  Most non-
typhoidal serovars have a broad range of animal hosts.  Typhoidal Salmonella serovars, including 
Salmonella Typhi (S. Typhi) and Salmonella Paratyphi A-C, are specifically adapted to humans 
or higher primates and cause typhoid fever or paratyphoid fever (Spanò and Galán, 2012).   
 
  2 
 
Fig. 1-1.  Classification of Salmonella species and subspecies.  The last column indicates the 
human syndrome caused by Salmonella serovars.  The permissible host types are shown in 
brackets.  S. Typhi and Paratyphi are human-specific and other serovars have a broad range of 
hosts. 
1.3 Salmonella type three secretion systems (TTSS) 
Like the human multilayer defense systems, bacteria evolved various strategies to 
overcome the host’s defense mechanisms in order to colonize, to persist and to spread.  These 
strategies include structural, biochemical, and genetic modification of bacteria.  Understanding 
how Salmonella survives the immune response is of great importance to fully understand 
Salmonella pathogenicity.   
The genome of S. Typhimurium consists of a ~4,800 Mb chromosome and an additional 
~95 kb virulence plasmid (Fig. 1-2.A) (Sabbagh et al., 2010).  It was estimated that about 4% of 
the Salmonella genome is required for bacterial virulence (Bowe et al., 1998).  Most of the 
virulence genes are located within the Salmonella-pathogenicity islands (SPIs).  The SPIs are 
large cassettes composed of a series of genes and operons (Marcus et al., 2000).  Five SPIs have 
been identified in S. Typhiumurium.  SPI-1 and SPI-2 are of greatest importance for bacterial 
virulence because each encodes a type III secretion system (TTSS), which are used to deliver 
virulent proteins, called effectors, directly from the bacterial cytoplasm to the host cytosol.  SPI-
1 and SPI-2 not only encode TTSS but also the proteins that are secreted through these two 
secretion systems, proteins that regulate the expression of SPI-1 and SPI-2, as well as other 
  3 
proteins that help bacterial survival (Fig. 1-2.B) (Moest and Méresse, 2013).  Effectors are 
injected into the host cells through TTSS to create a pathogen-favorable environment (Wilson et 
al., 2011; Galán et al., 2014).   
TTSS is a multi-mega Dalton complex, formed by more than 20 proteins.  TTSS has a 
complex architecture with four main parts: the basal body, the needle, the needle tip and the 
translocon (Fig. 1-3) (Galán and Wolf-Watz, 2006; Galán et al., 2014).  The basal body is formed 
by proteins that oligomerize into ring structures, which are embedded in the bacterial inner and 
outer membrane (Bergeron et al., 2013).  The basal body structure associates with chaperons and 
ATPase on the cytoplasmic side of the inner membrane (Diepold and Wagner, 2014).  A needle-
like ~50 nm channel, called the needle filament, adapts to the basal structure and protrudes 
outside the bacterial membrane (Kubori et al., 2000).  At the end of the needle filament is a tip 
complex that detects and contacts the host cell and regulates the secretion of effectors.  The tip 
complex also facilitates the insertion of a translocon complex into the host membrane.  The 
translocon complex opens a pore in the host membrane to allow the effectors to enter the host 
cytosol (Burkinshaw and Strynadka, 2014).   
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Fig. 1-2.  Representation of the S. Typhimurium genome and SPI-1 and SPI-2.  A. Schematic 
representation of S. Typhimurium genome.  The figure is modified from (Marcus et al., 2000).  
S. Typhimurium genome is comprised of a chromosome and a separate virulence plasmid.  The 
essential SPIs and the spv locus are labeled in the chromosome and on the plasmid.  The 
respective sizes of SPIs and the virulence plasmid are labeled (Marcus et al., 2000).  B. 
Distribution of genes on SPI-1 and SPI-2.  The figure is adapted from (Hansen-Wester and Hensel, 
2001) with permission.  The functional classes of SPI-1 and SPI-2 genes are represented by 
different colors.   
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Fig. 1-3.  The structure and composition of Salmonella TTSS.  A. Cryo EM image of Salmonella 
TTSS, adapted from (Kosarewicz et al., 2012) with permission.  B. Surface representation of a 
3-D reconstruction of TTSS based on cryo-EM data.  This figure is adapted from (Diepold and 
Wagner, 2014) with permission.  The complex consists of the basal structure and the needle 
filament.  OM indicates the outer membrane and IM the inner membrane.  Neck indicates the 
region connecting the outer and inner membrane ring structures.  C. Salmonella TTSS 
components. (a) schematic representation of TTSS structure, (b) structural elements of TTSS, (c) 
and (d) protein components according to structural elements for TTSS-1 and TTSS-2.  The figure 
is modified from (Moest and Méresse, 2013) with permission.   
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1.4 Overview of the functions of Salmonella effectors 
Although the two Salmonella TTSS are similar in their overall structures, effectors 
secreted through these two systems are different and they perform different functions.  More than 
30 effectors secreted through both TTSS have been identified (Bakowski et al., 2008).  Generally, 
TTSS-1 and its substrates are more likely to affect the invasion of bacteria while TTSS-2 and its 
substrates promote intracellular survival (Paesold et al., 2002).   
The expression of Salmonella TTSS-1 and TTSS-2 and the delivery of effectors during 
infection of intestinal epithelial cells are summarized in a schematic flow diagram (Fig. 1-4).  
Salmonella pre-assembled TTSS-1 senses and adheres to the host cells (Schlumberger et al., 
2005).  The adherence triggers the full assembly of TTSS-1 and the injection of effectors that 
rearrange the actin cytoskeleton (Zierler and Galán, 1995; Schlumberger et al., 2005; Bakowski 
et al., 2007).  This actin rearrangement causes ruffling of the host cell membrane and the 
engulfment of bacterium (Hardt et al., 1998; Jepson et al., 2001; Buchwald et al., 2002; Williams 
et al., 2004).  The engulfed bacterium remains in a separated compartment, called the Salmonella-
containing vacuole (SCV) (Steele-Mortimer, 2008).  Meanwhile, more TTSS-1 are assembled 
and more TTSS-1 effectors are expressed and secreted into the host cytoplasm to help stabilize 
the SCV and to alter the host cell signaling pathways (Schlumberger and Hardt, 2006).  Once 
inside the host cells, the expression of TTSS-1 and its substrates is downregulated.  The TTSS-1 
effectors are degraded by the host proteasome pathways at different rates (Schlumberger and 
Hardt, 2006).  When TTSS-1 is downregulated, the expression of SPI-2 and its effectors is 
upregulated in the acid vacuole (Fierer et al., 1993; Chen et al., 1996).  TTSS-2 effectors are 
further secreted to manipulate the host cytoskeleton and to direct SCV maturation (Figueira and 
Holden, 2012).  Bacterium replicates inside the mature SCV (Bakowski et al., 2008).   
The expression of TTSS-1 and TTSS-2 effectors is strictly regulated by the bacterium, 
both temporally and spatially, (Schlumberger and Hardt, 2006).  This is particularly evident when 
the two effectors have opposite functions.  The functions of effectors can be classified into four 
groups: (1) acting as translocon components to be inserted into the host membranes, (2) 
interfering with host cytoskeleton dynamics, (3) directing SCV dynamics and (4) mediating host 
signaling pathways (Table 1-1).  TTSS effectors are not limited to the effectors listed in Table 1-
1.  For several effectors their functions are still unknown.  
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Fig. 1-4.  Schematic overview of the expression of Salmonella TTSS-1 and TTSS-2 and the 
delivery of effectors during infection of intestinal epithelial cells.  The contact between bacterium, 
pre-loaded with TTSS-1 apparatus (yellow) and effectors (squares), and the host cell initiates the 
translocation of effectors that cause host cytoskeleton rearrangement resulting in bacterial 
engulfment.  The engulfed bacterium remains within the SCV, a replication niche.  Once inside 
the host cell, the expression of TTSS-1 and its effectors is downregulated, while expression of 
TTSS-2 (blue) and its substrates (circles) is upregulated.  The secreted TTSS-2 effectors guide 
the maturation of SCV.  Bacterium replicates inside the mature SCV.  The figure is adapted from 
(Schlumberger and Hardt, 2006) with permission.   
 
Table 1-1.  Overview of functions of Salmonella effectors secreted though TTSSs. 
Effectors Function Host cell targets Reference 
TTSS-1 substrates 
Translocon components 
SipB(SspC) 1. A TTSS Translocon; 
2. Activates pro-apoptotic enzyme 
caspase 1. 
cytokeratin 8; 
caspase 1 
(Scherer et al., 2000; 
Barta et al., 2012) 
SipD TTSS Translocon ? (Collazo and Galán, 
1997) 
Cytoskeleton dynamic 
SptP 1. A tyrosine phosphate; 
2. A GTPase activating protein 
(GAP) that disrupts of actin 
cytoskeleton. 
Cdc42, Rac1 (Stebbins and Galán, 
2000) 
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SopE Mimics eukaryotic guanine 
exchange factors (GEFs) 
Cdc42, Rac1, 
Rab5 
(Buchwald et al., 
2002) 
SopE2 Mimics GEFs Cdc42 (Williams et al., 
2004) 
SipA Polymerizes actin  actin (Lilic et al., 2003) 
SipC 1. Direct binds to actin; 
2. Nucleates actin polymerization; 
3. Condensates actin filaments into 
cables. 
actin (Hayward and 
Koronakis, 1999) 
SCV membrane dynamic 
SopB 1. A phosphoinositide 
phosphatase; 
2. Mimic host guanine dissociation 
inhibitor (GDI). 
Membrane 
phospholipid, 
Cdc42 
(Burkinshaw et al., 
2012) 
SopD* 
 
1. Plays a role in membrane fission 
and macropinosome formation; 
2. Acts cooperatively with SopB to 
promote host cytoskeleton 
rearrangement. 
? (Bakowski et al., 
2007) 
SopD2* 
 
1. Mediates SCV trafficking;  
2. Promotes the formation of 
Salmonella-induced filaments. 
Rab7 (Jiang et al., 2004) 
GtgE A cysteine protease Rab29, Rab32 and 
Rab38 
(Spano et al., 2011; 
Spanò and Galán, 
2012) 
Cell immune signaling 
AvrA 1. An acetyltransferase; 
2. Inhibits JNK, MAPKs activity. 
MKK7 (Du and Galán, 2009; 
Wu et al., 2012) 
 
SopA E3 ubiquitin-protein ligase Ubiquitin 
pathway E2 
enzymes: 
UbcH5a, UbcH5c 
and UbcH7.  
(Higashide and 
Zhou, 2006; Zhang et 
al., 2006; Diao et al., 
2008) 
 
SspH1* 1. An E3 ubiquitin-protein ligase; 
2. Polyubiquitinates host PKN1. 
Ubiquitin 
pathway E2 
enzymes; PKN1 
(Haraga and Miller, 
2006) 
GtgE A cysteine protease Rab29, Rab32 and 
Rab38 
(Spano et al., 2011; 
Spanò and Galán, 
2012) 
 
TTSS-2 substrates 
Cell immune signaling 
SseL A deubiquitinase 
 
Ubiquitin, 
ubiquitin 
(Rytkönen et al., 
2007) 
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conjugated 
proteins 
SspH2 An E3 ubiquitin ligase Ubiquitin 
pathway E2 
enzymes 
(Quezada et al., 
2009) 
SCV membrane dynamic 
SsaB (SpiC) Interferes with intracellular 
trafficking 
 
 
Potentially 
HOOK3 protein 
(Uchiya et al., 1999) 
SifA 1. Promotes the formation of 
Salmonella  induced filaments 
(Sifs);  
2. Mimic GEFs. 
 
SKIP and 
RhoA-family 
GTPases: RhoA, 
RhoB and RhoC 
(Brumell et al., 
2002; Boucrot et al., 
2005; Ohlson et al., 
2008) 
 
PipB2 1. Links kinesin-1 onto SCV 
membrane; 
2. Required for centrifugal 
extension of Sifs. 
kinesin-1 (Henry et al., 2006) 
SseJ 
 
1. Negatively regulates the 
formation of Sifs; 
2. A deacylase; 
3. A cholesterol esterification 
protein. 
cholesterol (Ohlson et al., 2005; 
Nawabi et al., 2008)  
 
Effectors with unknown delivery pathways 
SpvB An actin mono-ADP-
ribosyltransferase 
actin (Hochmann et al., 
2006; Margarit et al., 
2006)  
SpvC A phosphothreonine lyase that 
irreversibly inactivates host MAP 
kinases  
MAPK2/ERK2, 
MAPK3/ERK1, 
and p38 
(Li et al., 2007; 
Chen et al., 2008; 
Mazurkiewicz et al., 
2008) 
The * indicates that effectors are also secreted though SPI-2 TTSS.  
1.5 GtgE is a virulence protein cleaving Rab29, Rab32 and Rab38 
1.5.1 Overview of the biogenesis of Salmonella-containing vacuole 
Phagocytosis is an important defense mechanism for the host cells in fighting against 
bacterial infection (Steele-Mortimer, 2008).  Rab GTPases are important for mediating the 
phagosome dynamic (Smith et al., 2007) and it is not surprising that they are targeted by effectors.  
Rab (Ras-related in brain) proteins belong to the Ras superfamily of small GTPases (Touchot et 
al., 1987).  Four Rabs, Rab1-4, were first identified when using oligonucleotide strategy to clone 
YPT (a Ras member in yeast) related cDNAs from the mice brain library (Touchot et al., 1987).  
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Rab GTPases play essential role in the regulation of membrane identity, vesicle formation, 
vesicle and organelle motility and vesicular trafficking (Stenmark and Olkkonen, 2001; Zerial 
and McBride, 2001; Pfeffer, 2013).  Protein markers Rabs (Rab8B, Rab13 and Rab35) are 
translocated into the classic phagosome membrane, which contains non-invasive bacteria.  These 
proteins are shown to promote the fusion of phagosome to lysosome (Fig. 1.5) (Bakowski et al., 
2008).  The phagosome is also quickly acidified through the action of vacuolar ATPase in the 
phagosome membrane, which pumps H+ into the phagosome.  The acidified and matured 
phagosome is directed to fuse with the lysosome, which releases anti-microbial proteins to 
destroy the invader (Bakowski et al., 2008; Steele-Mortimer, 2008).   
Unlike the classic phagosome, SCV matures differently to avoid the fusion with lysosome 
(Brumell and Grinstein, 2004).  The maturation of SCV depends on the recruitment of lipids and 
different endocytic protein markers, such as small GTPases Rab5, Rab7 and Rab11 (Fig. 1-5) 
(Knodler and Steele-Mortimer, 2003).  Upon formation of SCV, a TTSS-1 effector SopB is 
secreted to acquire Rab5, which directs vesicular trafficking, onto the SCV membrane (Mallo et 
al., 2008).  Subsequently, Rab5 attracts a phosphatidylinositol 3-kinase Vsp40 which generates 
phosphatidylinositol 3-phosphate (PI3P) and blocks phago-lysosome fusion (Mallo et al., 2008).  
PI3P in turn attracts early endosome-associated protein EEA1, which also binds to Rab5 (Mallo 
et al., 2008; Steele-Mortimer, 2008).  Bacteria also use SopB to recruit sorting nexin1 protein, 
which removes the late-endosomal marker mannose 6-phosphate receptor from the membrane 
(Bujny et al., 2008).  Moreover, SopB is also involved in the activation of Rab14, which delays 
the SCV-lysosome fusion and facilitates bacterial replication inside the SCV (Kuijl et al., 2007).   
The maturation of SCV also requires SopD2, which interacts with a late endosome protein 
marker Rab7, although bacteria try to limit the interaction between SCV and the late endosome 
(Brumell et al., 2003).  Rab7 attracts Rab-interacting lysosomal protein (RILP), which bridges 
the Rab7-containing membrane with the microtubule dynein motor complex (Cantalupo et al., 
2001; Ramsden et al., 2007).  With the help of Rab7 and RILP, SCV traffics along the 
microtubules.  Effector SseJ is also found to mediate SCV dynamics by esterifying cholesterol in 
the SCV membrane (Ruiz-Albert et al., 2002).  Several effectors, such as SifA, SopA, SopD2, 
SspH2, and SsaB, are involved in mediating the SCV-associated actin dynamics and the 
formation of Salmonella induced filaments (SIFs), which are essential for SCV trafficking 
(Brumell and Grinstein, 2004; Ramsden et al., 2007; Bakowski et al., 2008; McGhie et al., 2009).   
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Fig. 1-5.  Biogenesis of SCV.  Endosomal markers on the pathogenic SCV (left) compared with 
markers (right) acquired by a model phagosome containing the ΔinvA/inv strain of S. 
Typhimurium, which is non-invasive.  The figure is adapted from (Steele-Mortimer, 2008) with 
permission.  
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1.5.2 GtgE is an important virulence effector for S. Typhimurium 
In S. Typhimurium, GtgE is a protein encoded within the Gifsy-2 lambdoid prophage.  
The Gifsy prophage is present in three S. Typhimurium strains, ATCC14028s (Fields et al., 1986), 
SL1344 (Hoiseth and Stocker, 1981) and LT2 (Figueroa‐Bossi et al., 2001).  The Gifsy-2 
prophage plays an essential role in bacterial virulence, as evidenced by the attenuated virulence 
seen in strains lacking this prophage (Figueroa‐Bossi and Bossi, 1999).  Gifsy-2 also encodes 
a periplasmic Cu/Zn superoxide dismutase named SodCI (De Groote et al., 1997; Farrant et al., 
1997), which protects bacteria by clearing peroxides produced by the host cells (De Groote et al., 
1997).  There are ~10 putative virulence genes encoded within the Gifsy-2 prophage (Fig. 1-6).   
 
 
Fig. 1-6.  Schematic representation of Gifsy-2 prophage.  A. Open reading frame of Gifsy-2 
prophage.  Most of the genes are termed gft (Gifsy-2), e.g., gftO and are labeled with a single 
additional letter.  White arrows represent putative virulence genes.  Gray arrows represent 
putative phage genes and lines indicate deletion intervals.  B. Gene organization of the region 
encoding putative effectors.  Genes with no obvious role in phage production are termed gtg 
(Gifsy-2 gene) (Figueroa‐Bossi et al., 2001).  The Figure is modified from (Ho et al., 2002) 
with permission. 
 
To understand the functions of the putative virulence genes, individual putative effector 
genes were deleted using the λ red recombinase method and the virulence of a target gene was 
measured by a competition assay (Ho et al., 2002).  To conduct a competition assay, mutant and 
wild-type strains were mixed in a 1:1 ratio and inoculated into mice.  After 4-5 days post infection, 
bacteria from an infected mouse were plated on an LB plate, which selects for the infecting 
bacteria.  In this way, the recovery ratio of mutant and wild-type strains could be determined.  
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This value is designated as the competition index (CI), which is used to quantify the level of 
virulence (Wilson et al., 2011).  The lower the CI, the less virulent the strain and thus the more 
significant the deleted gene to virulence.  The ΔsodCI mutant and the ΔgtgE mutant had a CI of 
~0.15 while the ΔGifsy-2 mutant had a CI of ~0.01 (Ho et al., 2002).  When the ΔGifsy-2 mutant 
strain was complemented with the gtgE-containing plasmid, bacteria behaved like the wild-type 
strain (Ho et al., 2002).  These experiments identified the SodCI and GtgE genes as the major 
virulence determinants carried by Gifsy-2 in S. Typhimurium (Ho et al., 2002).   
1.5.3 GtgE affects the host specificity of S. Typhi 
S. Typhimurium has a broad range of hosts, while S. Typhi is human-specific.  S. Typhi 
produces a unique virulence protein called typhoid toxin, which is an AB toxin with a DNase and 
an ADP-ribosyltransferase activities (Haghjoo and Galán, 2004).  Typhoid toxin is expressed 
exclusively inside the host cells and is transported to the extracellular environment by vesicular 
transport (Spanò et al., 2008).  Considering that Rab GTPases are usually involved in vesicular 
trafficking, a siRNA screen targeting human Rab and Rab-like GTPase was performed to identify 
GTPases that were required for typhoid toxin transport (Spano et al., 2011).  It was found that 
deletion of Rab29 decreased the amount of typhoid toxin transport intermediates (Spano et al., 
2011).   
Rab29 was further characterized to be present on the SCV membrane of S. Typhi, but not 
on the SCV membrane of S. Typhimurium (Spano et al., 2011).  The differential recruitment of 
Rab29 on SCVs was caused by a TTSS-1 substrate GtgE (Spano et al., 2011).  GtgE is present 
in S. Typhimurium but not in S. Typhi (Spano et al., 2011).  When S. Typhi was complemented 
with the gtgE gene from S. Typhimurium, S. Typhi propagated more efficiently within the SCV 
than its wild-type counterpart (Spano et al., 2011).  Moreover, S. Typhi complemented with the 
gtgE gene showed significantly increased survival ability in primary bone-marrow-derived 
macrophages from mice, a non-permissive species (Spanò and Galán, 2012).  This indicated that 
the expression of the S. Typhimurium effector GtgE in S. Typhi permitted S. Typhi to overcome 
the host restriction barrier.   
1.5.4 GtgE directly cleaves Rab29 
GtgE is essential for the depletion of Rab29 on the SCV membrane.  It was found that 
Rab29 was present on the SCV membrane in cells infected with S. Typhimurium ΔgtgE strain, 
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but not the wild-type strain (Spano et al., 2011).  Cleavage of Rab29 by GtgE was confirmed 
through in vitro experiments.  The purified GtgE was treated with Rab29-GFP fusion in a buffer 
containing Ca2+ and Mg2+ and an anti-GFP antibody was used to detect the GFP-tagged protein 
on a Western blot.  In addition to Rab29-GFP, a specific band with a lower molecular weight was 
present, confirming that GtgE cleaves Rab29 (Spano et al., 2011).   
To identify the cleavage product, Rab29 fused a 3×Flag at the C-terminal was co-
expressed with GtgE in E. coli (Spano et al., 2011).  The cells expressing both proteins were 
lysed and the supernatant was loaded on an anti-Flag M2 affinity gel to purify the cleaved product.  
The cleaved product was subjected to N-terminal sequencing, which revealed the cleavage site.  
It was identified that the Rab29 cleavage occurred after Gly41 (Spano et al., 2011).   
Other GTPases were tested as possible GtgE targets.  Although most Rabs and Rab-like 
GTPases exhibit a broad residue conservation of residues in the region around Gly41 of Rab29, 
only Rab29, Rab32 and Rab38 were identified as GtgE substrates (Fig. 1-7) (Spanò and Galán, 
2012).  Rab32 and Rab38 function in the biogenesis of lysosome-related organelle complexes 
that deliver their cargos to lysosome-related organelles.  These cargos include enzymes required 
for melanine synthesis and a variety of antimicrobial proteins, which promote elimination of the 
SCV (Dell’Angelica, 2004; Bultema et al., 2012).  Therefore, GtgE cleavage of Rab29, Rab32 
and Rab38 helps to avoid fusion of SCV with lysosomes.   
 
Fig. 1-7.  Multiple alignment of the closely related Rab GTPases Rab32, Rab38 Rab29 and Rab23. 
The arrow represents the cleavage site of Rab GTPases by GtgE.  The figure is adapted from 
(Spanò and Galán, 2012) with permission.   
 
1.5.5 GtgE is a cysteine protease  
To identify the mechanism of the GtgE proteolytic activity, its primary sequence was used 
to search for homologs (Spano et al., 2011).  It was found that GtgE showed ~14% sequence 
identity and ~24% similarity to a cysteine protease caricain (Fig. 1-8).  Cysteine proteases are 
present in all living organisms (Grzonka et al., 2000).  The catalytic residues Cys and His are 
evolutionarily conserved in all cysteine protease and frequently form a Cys-His-Asp catalytic 
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triad (Grzonka et al., 2001).  Cysteine and histidine form an ion pair Cys-S- … H+-His at pH 3.5-
8.0 (Grzonka et al., 2001).  The deprotonated Cys-S- acts as a nucleophile and attacks the 
electrophilic carbonyl carbon of the peptide bond of the substrate.  The intermediate attracts the 
proton from H+-His to form a thioester and releases the amine terminus of the substrate.  The 
thioester is subsequently hydrolyzed to regenerate the nucleophile Cys-S- with the releasing of 
the remaining substrate fragment (Polgár and Asbóth, 1986).   
 
 
Fig. 1-8.  Sequence alignment of GtgE and caricain.  In the middle line a single dot indicates 
similar residues, double dots mark residues with higher similarity and vertical lines represent 
identical residues.  This sequence allignment was generated through EMBL-EBI Pairwise 
Sequence Alignment server http://www.ebi.ac.uk/Tools/psa/.   
 
To verify that GtgE is a cysteine protease, each cysteine in GtgE was mutated to an alanine 
(Kohler et al., 2014).  Only the C45A mutant lost the in vitro protease activity, indicating that 
Cys45 is the critical residue in the active site (Kohler et al., 2014).  His151 was predicted to be a 
component of the catalytic triad based on sequence alignment with other cysteine proteases and 
indeed H151A mutation resulted in a loss of protease activity (Spano et al., 2011; Spanò and 
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Galán, 2012).  The third catalytic residue of the triad was identified as Asp169 by point mutation 
studies.   
A structure of a GtgE fragment spanning residues 80 to 213 was recently reported (Fig.1-
9.A) (Kohler et al., 2014).  The structure contains five α helices and five anti-parallel β strands, 
forming a globular structure.  The catalytic residue Cys45 is not present in the fragment and the 
catalytic residues His151 and Asp169 are present on the protein surface and in a conformation 
that is not consistent with an active state.  The substrate binding site is not obvious due to the 
lack of the first 79 N-terminal residues.  
The peptidase database MEROPS classifies peptidases into clans, which contain 
evolutionary related proteins (Rawlings et al., 2013).  Members of cysteine protease families 
perform various biological functions.  The structure of GtgE(80-213) is folded similarly to other 
cysteine proteases, specifically to the cysteine protease from clan CA family C39 (Kohler et al., 
2014).  GtgE(80-213) aligns well with the C39 member ComA at the peptidase domain (Fig.1-9.B) 
(Kohler et al., 2014). The first letter C in the clan CA indicates a cysteine protease family.  The 
C39 family contains bacteriocin-processing endopeptidases from bacteria (Wu and Tai, 2004).  
ComA from Streptococcus is a bacteriocin transporter with a peptidase domain on the N-terminal 
region (Ishii et al., 2010).  
Although the structure of GtgE(80-213) aligns well with the peptidase domain of ComA, the 
orientations of His151 and Asp169 are different with respect to the catalytic residues His96 and 
Asp112 from ComA (Fig. 1-9).  This difference in orientation may arise from the absence of the 
N-terminal region of GtgE, which includes Cys45.  As a result, the crystallized GtgE fragment 
represents an inactive conformation.   
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Fig. 1-9.  Structure of GtgE(80-213) and its superposition with ComA.  A. Cartoon representation 
of GtgE(80-213) structure.  B. Structural alignment of GtgE(80-213) (green) with the peptidase domain 
of ComA (PDB entry 3K8U, purple).  The active site residues of GtgE(80-213), His151 and Asp169 
(labelled in bold), are in similar location as the active His96 and Asp169 (labelled in bold italics) 
of the ComA peptidase domain.  The figures are adapted from (Kohler et al., 2014) with 
permission. 
 
1.6 SpvB is a virulence protein disrupting the host actin cytoskeleton 
1.6.1 Bacterial proteins (effectors or toxins) affecting actin rearrangement 
Actin is a component of microfilaments (Lodish, 2008), one of the three eukaryotic 
cytoskeletons.  Both the monomeric globular actin (G-actin) and polymerized filament (F-actin) 
play important roles in eukaryotic cell motility, organelle movement, cell division and the 
maintenance of cell shape (Lodish, 2008).  Salmonella secretes a series of effectors through 
TTSS-1 to manipulate the actin cytoskeleton in order to invade the host cell.  SPI-1 effectors, 
SopE and SopE2 are involved in the activation of cytoskeletal regulation proteins Cdc42 and 
Rac1, resulting in the recruitment of WASP and Scar/WAVE family proteins to the Arp2/3 
complex (Buchwald et al., 2002; Williams et al., 2004; Burkinshaw et al., 2012).  The Arp2/3 
complex is involved in the initialization of actin polymerization (Criss and Casanova, 2003) and 
is predominantly regulated by proteins belonging to the WASP and Scar/WAVE families 
(Millard et al., 2004; Pollitt and Insall, 2009).  Besides, SPI-1 effectors SipA and SipC interact 
directly with actin (Hayward and Koronakiss, 2002).  SipA functions as a molecular staple, which 
has a globular domain and two extended non-globular “arms”.  The globular domain interacts 
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with the acidic patch on the C-terminus of actin and the extended arms tether to actin protomers 
on the opposite strands of actin filament (Lilic et al., 2003).  The interaction between SipA and 
actin stabilizes polymerized actin and promotes the formation of F-actin (Lilic et al., 2003).  SipC 
is a component of the SPI-1 translocon and is also secreted into the host.  The N-terminal region 
of SipC bundles actin filament and the C-terminal domain nucleates actin polymerization 
(Hayward and Koronakis, 1999).  The exact role of SipC in actin rearrangement remains unclear, 
since its genetic deletion, the ∆sipC mutant, failed to assemble SPI-1 and was unable to deliver 
SPI-1 effectors (Guiney and Lesnick, 2005).   
Actin rearrangement occurs not only during bacterial invasion but also continues during 
the intracellular infection process.  After Salmonella gains entry into the host cell, SPI-1 effectors 
are downregulated.  In spite of this global downregulation, the SPI-1 effector SptP persists in the 
cytoplasm.  SptP acts as a GTPase-activator and a tyrosine phosphatase (Stebbins and Galán, 
2000).  The GTPase activation domain of SptP reverses the activation of Cdc42 and Rac1, which 
is caused during Salmonella invasion (Stebbins and Galán, 2000; Galán, 2001).  SptP is believed 
to function in the restoration of normal actin cytoskeleton functions, which are disrupted during 
invasion (Galán, 2001).  SPI-2 effectors SspH2 and SseI, which show sequence similarity in their 
N-terminal regions, co-localize with the polymerized actin, which is believed to result from the 
interactions of their homologous N-terminal regions with filamin, a protein that holds actin 
filaments in eukaryotic cells (Miao et al., 2003).  It was found that SspH2 also interacts with 
profilin, a protein involved in actin cytoskeletal dynamics (Miao et al., 2003).  A number of S. 
enterica strains employ SpvB to modify actin by ADP-ribosylation, which prevents actin 
polymerization (Guiney and Lesnick, 2005).  Ubiquitously, Salmonella secretes a series of 
effectors to regulate the cytoskeletal dynamics of actin.   
1.6.2 Spv locus 
SpvB is encoded within the spv locus, which is located on a separate virulence plasmid in 
S. enterica subspecies I lineage and on the chromosome in some other S. enterica linages (Libby 
et al., 2002).  The spv locus plays an important role in bacterial virulence.  A S. Typhimurium 
strain with a spv deletion showed reduced virulence in terms of LD50 values in mice (Fierer et al., 
1992; Libby et al., 1997).  The spv operon encodes a transcriptional regulator, SpvR, and four 
structural proteins SpvABCD (Fig.1-10) (Guiney and Fierer, 2011).  The initial transcription of 
SpvR is regulated by RpoS, a stationary phase sigma factor (Fang et al., 1992; Chen et al., 1996).  
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Subsequently, SpvR and RpoS upregulate the expression of SpvABCD by interacting with 
upstream recognition sites of the spvR and spvA promoters (Sheehan and Dorman, 1998).  SpvB 
and SpvC increase the virulence of S. Typhimurium, while the functions of SpvA and SpvD 
remain unknown.  SpvC functions as a phosphothreonine lyase and targets the host mitogen-
activated protein kinases (MAPKs), which are essential for the host immune response 
(Mazurkiewicz et al., 2008).  SpvC inactivates MAPKs by removing the phosphate moiety from 
phosphothreonine in MAPKs and generates a double-bond-containing product by breaking the 
C-O rather than the O-P bond (Chen et al., 2008).  The inactivation of MAPKs suppresses the 
host’s pro-inflammatory responses and thereby facilitates the growth of bacteria (Haneda et al., 
2012).   
 
 
Fig. 1-10.  Map of the spv operon residing within the virulence plasmid of S. Typhimurium.  The 
operon encodes a regulator protein SpvR and four structural proteins, SpvABCD.  The 
transcription of SpvR is initiated by RpoS, a stationary phase sigma factor.  SpvR and RpoS 
upregulate the transcription of spvABCD by binding to the upstream promoters of spvR and spvA.  
The red line in the DNA sequence indicates the promoter sequences corresponding the genes.  
 
1.6.3 SpvB ADP-ribosylates G-actin, resulting in de-polymerization of F-actin 
SpvB from S. Typhimurium is a 591 amino acid long protein, folded into two domains 
linked by a short proline-rich segment.  The C-terminal domain of SpvB shows ~19% sequence 
identity to Bacillus cerues VIP2, which is an actin ADP-ribosylating toxin.  SpvB was 
demonstrated to function as an ADP-ribosyltransferase (ART) and its substrate was identified as 
actin (Tezcan-Merdol et al., 2001).  It was shown that SpvB ADP-ribosylates actin at Arg177 
(Hochmann et al., 2006).  This modification of actin results in the loss of polymerization activity, 
leading to the disruption of an equilibrium between G- and F-actin (Fig. 1-11) (Aktories et al., 
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2011; Barth and Aktories, 2011).  Disruption of the cytoskeleton by SpvB, initiates apoptosis 
(Paesold et al., 2002; Tezcan-Merdol et al., 2005), resulting in the uptake of infected cells by 
macrophages (Guiney, 2005).   
 
 
Fig. 1-11.  SpvB mediated actin cytoskeleton dynamics.  Inside the host cell, G- and F-actin are 
in an equilibrium.  In the presence of NAD+, SpvB transfers the ADP-ribosyl moiety to G-actin.  
The modified actin loses the ability to polymerize into F-actin, which shifts the equiliblium 
towards G-actin and leads to partial F-actin depolymerization.  Continous removal of G-actin by 
SpvB leads to complete depolymerization of F-actin cytoskeleton.   
 
The crystal structure of the SpvB ART domain in complex with NADH has been 
determined (Margarit et al., 2006).  Alignment of the SpvB ART domain structure with other 
ADP-ribosylating toxins showed similar core structures and active site clefts (Fig. 1-12).  
Relative to other ART domains, SpvB contains an insertion between the third and forth α-helices 
(Fig.1-12).   
Once ADP-ribosylated, actin loses its polymerization activity.  Two possible explanations 
for this loss of polymerization activity have been proposed, (1) the ADP-ribosylation of actin 
causes a significant conformational change, which results in a disruption of the actin filaments 
interfaces; (2) the modification results in a steric disruption of intra-filament contacts (Margarit 
et al., 2006).  To understand why the modification results in a loss of polymerization activity, 
structures of ADP-ribosylated actin were determined (Margarit et al., 2006).  Superposing the 
structures of the modified and wild-type actin showed only minor conformational differences, 
result which excludes the possibility that large conformational changes are responsible for the 
loss in actin polymerization activity.  However, the ADP-ribosyl moiety bound to Arg177 is 
present at the intra-filament interfaces of F-actin (Fig. 1-13), causing steric hindrance to prevent 
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the binding of another actin monomer.  This finding agrees with the latter possibility of abrogating 
actin polymerization (Margarit et al., 2006). 
 
 
Fig. 1-12.  Structures of SpvB(390-591) and its superimposition with other ART toxins.  A. Ribbon 
representation of the structure of SpvB ART domain in complex with NADH, shown as a ball-
and-stick model.  The conserved ADP-ribosylating toxin core structure is shown in yellow, and 
the insertion specific for SpvB is highlighted in red.  B. Structural alignment of SpvB with other 
ADP-ribosylating toxins (Diphtheria toxin, Iota-toxin, VIP2 and C3).  NADH is shown in a 
space-filling representation.  The figures are adapted from (Margarit et al., 2006) with permission.  
 
 
Fig. 1-13.  Steric clash due to the ADP-ribosylation in the actin helix.  The left panel shows the 
Holmes model of actin helix.  The middle panel is the magnification of the several actin protomers 
with Arg177 (blue) shown in space-filling representation.  The last panel is the superimposition 
of ADP-ribose (red) in space-filling representation with actin interfaces.  Putative residues (E195, 
S199, F200 and V201) interacting with Arg177 were shown in space-filling representation.  The 
relative size of ADP-ribose is much larger than other residues of the interface. Thus the ADP-
ribose actin would increase steric clash when it conjugated to Arg177.  The figure is adapted from 
(Margarit et al., 2006) with permission. 
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1.6.4 Comparison of the N-terminal domain of SpvB with the ABC toxins 
The structure and funtion of the SpvB ART domain are well characterized.  However, the 
structure and funtion of the larger N-terminal domain remain unknown.  The N-terminal domain 
of SpvB shows 47% sequence identity with the N-terminal region of YenB from Yersinia 
entomophaga and 49% with TcdB2 from Photorhabdus luninescens(Fig. 1-14).   
 
 
 
Fig. 1-14.  Sequence allignment of the N-terminal domain of SpvB with the N-terminal segments 
of TcdB2 and YenB.  Residues in red are hyphophobic, green are neutral, blue are negatively 
charged and purple are positively charged.  Symbols below the sequences indicate: a single dot 
marks similar residues, a double dot marks closer similarity and a star marks identical residues.  
This sequence allignment was generated through EMBL-EBI multiple sequence allignment 
ClustalW2 server, http://www.ebi.ac.uk/Tools/msa/clustalw2/.   
  23 
YenB and TcdB2 (~1,500 amino acid long) are the B components of ABC toxins (also 
called Tc toxins), a group of toxins that are comprised of three components A, B and C.  The 
ABC toxin complex is assembled to translocate the cytotoxic domain of the C component (TcC) 
into the cytosol of the host cell (Busby et al., 2013).  Crystal structures of ABC toxins from 
Yersinia entomophaga and Photorhabdus luninescens were recently determined (Busby et al., 
2013; Meusch et al., 2014).  When inserted into the host membrane, the A component (TcA) 
forms pentamers with a translocation channel in the center (Meusch et al., 2014).  The B 
component (TcB) and the N-terminal region (NTR) of the TcC form a bell-shaped canister (Fig. 
1-15).  The C terminal region (CTR) of TcC is burried inside the canister (Busby et al., 2013).  
The canister (TcB-TcCNTR) and the cargo (TcCCTR) complex is then docked onto the pentamer 
formed by TcA.  When induced by low pH, the TcA pentamer opens the central channel and the 
TcC is autocatalytically cleaved to free the cytotoxic domain which is then transported through 
the TcA channel.  The cytotoxic domain of TcC is released into the cytosol of the host cells. 
Genes encoding the ABC toxin components are usually located in the same locus.  
Interesteringly, there is some similarity between Tc components and Spv proteins.  The 255 
residues long SpvA encoded upstream of SpvB shows 19% sequence identity to the N-terminal 
region of TcA, a large protein of ~2,500 residues (Fig. 1-16).  SpvA is predicted to be an outer 
membrane-associated protein and the TcA is a transmembrane protein.  As discussed above, the 
N-termianl domain of SpvB shows sequence identity to the N-terminal segment of TcB.  
Moreover, the C-terminal domain of SpvB has the same activity as the C-terminal domain of 
some TcCs, like TccC3 and TccC5.  Although some similarity could be found between 
SpvA/SpvB and the Tc toxin, SpvA and SpvB might function differently because they are much 
smaller than TcA and TcB, respectively.  The N-terminal domain of the TcA homologous to 
SpvA accounts for only 10% of the TcA sequence and the N-terminal domain of TcB homologous 
to the N-termianl domain of SpvB spans only ~20% of the TcB sequence.  As no transmembrane 
helices are predicted within the SpvA and SpvB sequences, these proteins are unlikely to form a 
transmembrane channel to translocate the C-terminal domain of SpvB.  Furthermore, from the 
structure of the Tc complex, the TcB-TcA interface inolves domains with no homologs in SpvA 
and SpvB (Fig. 1-16).   
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Fig. 1-15.  The structure of YenB-YenC1NTR complex.  A. Cartoon representation of the complex.  
The YenC1NTR is colored blue, except for the C-terminus, which is cyan, the N-terminal domain 
of YenB is colored magenta (homolog of SpvB), the middle domain is red and the C-terminal 
domain is green.  B. The complex contains a central cavity shown here in a slice through the 
surface representation of the complex.  The color coding is the same as in A.  
 
 
 
Fig. 1-16.  Components of the ABC toxin from Photorhabdus luninescens and Yersinia 
entomophaga.  Domain structure of each component is marked in different colors and the known 
functions are annotated.  Protein residues number are labelled according to TcdA1, TcdB2 and 
TccC3.   
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1.6.5 Comparison of SpvB with actin ADP-ribosylating toxins 
A number of pathogens like Clostridium, Bacillus and Photorhabdus luminescens, secrete 
toxins and effectors that mediate actin cytoskeleton rearrangement (Barbieri et al., 2002; Aktories 
and Barbieri, 2005).  One of the common approaches to interfere with actin dynamics is actin 
ADP-ribosylation.  Actin ADP-ribosylating toxins can be classified into two groups, (1) those 
that modify actin at Arg177, which results in the depolymerization of F-actin, and (2) those that 
modify actin at Thr148, which promotes actin polymerization and actin aggregation (Aktories et 
al., 2011).  Toxins modifying Arg177 of actin normally contain two components, an enzyme 
component and a binding component (Aktories et al., 2011).  Thus this group of toxins are also 
called binary actin ADP-ribosylating toxins and includes the C2 toxin from Clostridium 
botulinum, Iota from Clostridium perfringens, VIP from Bacillus cerues, CDT from Clostridium 
difficile and CST from Clostridium spiroforme (Barth and Stiles, 2008; Simon et al., 2014). 
The mechanism of the delivery of the C2 toxin is well understood (Fig. 1-17).  The 
binding component (C2II) is activated by the pre-cleavage of the N-terminal region and then the 
remaining C-terminal part polymerized into a heptameric prepore structure (Schleberger et al., 
2006).  The heptamer interacts with the N-terminal binding domain of  the enzyme component 
(C2I).  The C2II heptamer is then recognized by the receptor on the host membrane, resulting in 
the ruffling of the host membrane and leads to internalization of the  toxin within an endosome.  
Triggered by low pH, the C2 toxin inserts into the endosomal membrane and the C2I component 
is then delivered to the cytoplam of the host cytosol where it modifies actin (Aktories and Barth, 
2004a, b).  The function of the C-terminal domain of SpvB is similar to that of C2I toxins.  
However, since SpvB is not associated with a C2II-like component, the delivery of SpvB is rather 
different from the binary actin-ADP-ribosylating toxins and likely occurs through the type three 
secretion system.   
1.6.6 The secretion of SpvB 
The delivery of SpvB appears to be different from the ABC toxins and binary actin-ADP-
ribosylating toxins.  TTSS are the major translocation pathways for a large number of virulence 
proteins. However, the previously reported in vitro secretion assay of SpvB in Δspi-1 mutant 
strain (ΔinvA) and Δspi-2 mutant strain (ΔssrA) indicated that SpvB was secreted into medium 
in both mutant strains, leading the authors to conclude that the secretion of SpvB is TTSS-
independent (Gotoh et al., 2003).  However, no secretion pathway for SpvB was as yet identified.  
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To firmly confirm that TTSS are indeed not utilized for SpvB secretion one would need to show 
that SpvB is secreted when both SPI-1 and SPI-2 secretion systems are non-functional.  However, 
indirect evidence suggests that SpvB is likely secreted primarily through the SPI-2 secretion 
system.  The expression of spv genes and SPI-2 TTSS is upregulated when Salmonella gains 
entry into the host cells (Fierer et al., 1993; Chen et al., 1996).  Moreover, several SPI-2 TTSS 
effectors such as SsaV, SsaB and SseB-D are required for the secretion of SpvB (Browne et al., 
2008).  
 
Fig. 1-17.  Model of action of the C2 binary actin ADP-ribosylating toxin.  The C2 toxin consists 
of an enzyme component (C2I) and a binding component (C2II).  The N-terminal region of C2II 
is cleaved and the remaining C-terminal part oligomerizes into a hepatmer, which subsequently 
binds to the N-terminal domain of C2I.  The C2 toxin complex binds to the receptor on the cell 
surface and triggers endocytosis.  Upon endosome acidification the C2 complex is inserted into 
the endosomal membrane, releasing the C2I component into the host cytosol to modify actin.  
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1.7 Project objectives 
S. Typhimurium can invade a broad range of hosts, while S. Typhi is human-specific.  
Expression of a single protein GtgE from S. Typhimurium in S. Typhi helped to overcome host 
restriction.  This indicated that GtgE plays a role in host permissiveness.  The GtgE was shown 
to cleave several Rabs but not all, despite their high sequence similarity in the cleaved region.  
To understand how GtgE differentiates between closely related Rabs,the three-dimensional 
structure of the active form of GtgE alone and with a bound substrate is needed. Currently, only 
the crystal structure of the GtgE fragment of lacking ~80 N-terminal residues is known and 
represents an inactive form of GtgE.  The missing segment includes the cysteine nucleophile, and 
represents.  The objectives of this project were to acquire structural information about the active 
form of GtgE and to understand the substrate specificity of GtgE.  Therefore the main efforts on 
this project were directed toward crystallization of GtgE, its structure determination and its 
complex with Rab32 or a peptide containing the cleavage site.   
SpvB is another important effector in S. Typhimurium.  It is known that SpvB ADP-
ribosylates actin and disrupts actin cytoskeleton.  The structure and function of the ART domain 
is well characterized.  However, the function and structure of the N-terminal domain remains 
unknown.  The objectives of this project were to obtain structural information about the N-
terminal domain of SpvB and to identify the function of this domain.   
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2. Methods and materials 
2.1 Materials and reagents  
The reagents used in this project are listed in Table 2-1.  Antibodies used for Western blot 
and immunocytochemistry are listed in Table 2-2.  Cell lines used are listed in Table 2-3.  Vectors 
and plasmids used in this project are listed in Table 2-4.   
 
Table 2-1.  Important reagents used in this project 
 Reagents Supplier 
 
 
 
 
 
 
For cloning 
KOD hot start DNA polymerase kit, 71086 EMD Millipore 
T4 DNA polymerase, M0203L NEB 
T4 DNA ligase and corresponding buffer, M0202S NEB 
DpnI, R0176L NEB 
XhoI, R0146L NEB  
EcoRI, M0211L NEB 
BglII, R0144L NEB 
PstI, R0140S NEB 
100×BSA NEB 
100 mM dCTP,and 100 mM dGTP, N0446S NEB 
NEBuffer 2, B7002S NEB 
NEBuffer 3.1, B7203S NEB 
DNA loading buffer, 28129 Norgen 
Gelgreen nucleic acid gel stain, 41005 Biotium 
QIAquick Gel Extraction Kit (250), 28706 Qiagen 
QIAprep Spin Miniprep Kit (250), 27106  Qiagen 
 
 
 
 
For protein 
expression, 
purification 
and 
crystallization 
Isopropyl β-D-1-thiogalactopyranoside (IPTG), BP1755-
100 
Thermo Fisher 
Scientific 
Yeast Extract, YEX401.205 BioShop 
Tryptone, BP1421-2 Thermo Fisher 
Scientific 
Sodium chloride (NaCl), SOD002.10 BioShop 
Magnesium chloride hexahydrate, MAG520.500 BioShop 
Potassium chloride, POC999.500 EMD Millipore 
Glycerol, G31-4 Thermo Fisher 
Scientific 
Potassium phosphate monobasic (KH2PO4), P285-500 Thermo Fisher 
Scientific 
Potassium phosphate dibasic (K2HPO4), PPD303.1 BioShop 
Dithiothreitol (DTT), BP17225 Thermo Fisher 
Scientific 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), HEP001.1 
BioShop 
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Bis-Tris, BST602.250 BioShop 
Imidazole, IMD508.1 BioShop 
Nickel (II) sulfate hexahydrate, 227676-500G  Sigma-Aldrich 
L-Glutathione (GSH), GTH003.25 BioShop 
Formaldehyde, 04018 Polysciences, Inc. 
Protein marker, 161-0377 Bio-Rad 
Borane dimethylamine complex, 180238-5G Sigma-Aldrich 
Glycine, BP381-5 Thermo Fisher 
Scientific 
Sodium dodecyl sulfate (SDS), SDS001.1 BioShop 
30% Acrylamide/Bis-acrylamide(29:1), ACR009.500 Bioshop 
Ammonium persulfate (APS), AMP001.25 BioShop 
N,N,N,N-Tetramethylethane-1,2-diamine (TEMED), 
TEM001.25 
BioShop 
Bromophenol Blue, 114413-5G Sigma-Aldrich 
Coomassie Brilliant Blue R-250, (0427-25G) AMRESCO 
Tween-20,170-6531 BioShop 
Polyethylene glycol 3350 (PEG3350), P4338-1KG Sigma-Aldrich 
Polyacrylic acid 5100 sodium salt, 1132 Sigma-Aldrich 
Halt Protease Inhibitor Cocktail EDTA free, PI78439 Thermo 
Scientific 
Ni-NTA agarose, 142338540 Qiagen 
Hitrap chelating column, 17-0409-03 GE Healthcare 
Life Science 
Glutathione superflow resin, 635608 Clontech 
MonoQ 4.6/100PE, 17-5179-01 GE Healthcare 
Life Science 
Superdex 75 10/300, 17-5174-01 GE Healthcare 
Life Science 
 
For Cell 
culture 
Dulbecco’s Modified Eagle’s medium,D5796 Sigma 
XtremeGENE HP DNA Transfection reagent, 
06366236001 
Roche 
Trysin-EDTA solution, T4049-500ML Sigma 
Triton X-100, BP151-500 Thermo Fisher 
Scientific 
Ethylenediaminetetraacetic acid (EDTA), EDS-500G Sigma-Aldrich 
Paraformaldehyde, P6148-500G Sigma-Aldrich 
Fetal Bovine Serum (FBS), 10437-028 Life technologies 
4',6-diamidino-2-phenylindole (DAPI), D9542 Thermo Fisher 
Scientific 
Acti-stain 555 phalloidin, PHDH1-A Cytoskeleton Inc. 
Nitroblue tetrazolium/ 5-bromo-4-chloro-indolyl 
phosphate (BNT/BCIP), 34042 
Life Technologies 
ECL reagent 1 and 2, RPN2109 GE Healthcare 
Life Science 
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Table 2-2.  List of primary and secondary antibodies used in this project 
Antibody Supplier 
Mouse anti-HA (1:1000) Santa-Cruz-Biotechnology 
Mouse anti-FLAG (1:1000) Sigma-Aldrich 
Mouse anti-DnaK (1:10000) Sigma-Aldrich 
Rabbit anti-SseL serum (1:2000) W. Koester, Vaccine and 
Infectious Disease Organization 
(VIDO), Saskatoon 
Rabbit anti-SopE serum (1:2000) 
Goat anti-mouse-alkaline phosphatase (1:2000) 
Goat anti-Rabbit-alkaline phosphatase (1:10000) 
Goat anti-mouse- horseradish peroxidase (HRP) (1:5000) Santa-Cruz-Biotechnology   
 
Table 2-3.  List of cell lines used in this project 
 Cell lines Source 
Mammalian 
cell lines 
HeLa Dr. W. Xiao, Department of 
Microbiology and Immunology, 
University of Saskatchewan 
(Usask) 
Human embryonic kidney 293 (HEK293) 
E. coli 
strains 
DH5α Dr. M. Cygler, Department of 
Biochemistry, Usask BL21 
BL21(DE3) 
Bl21(DE3)STAR 
Salmonella 
strains 
Salmonella Enteritis strain 18 Dr. W. Koester, VIDO, 
Saskatoon 
 
 
 
Salmonella Enteritis Strain 18 with Δspi-
1::Amp & Chloramphenicol (Δspi-1 strain) 
Salmonella Enteritis Δspi-2::Amp & 
Chloramphenicol (Δspi-2 strain) 
Salmonella Enteritis Δspi-1&2::Amp & 
Chloramphenicol (Δspi-1&2 strain) 
 
Table 2-4.  List of plasmids used in this project 
Plasmid Description Source 
pMSCG7 Ampcillinresistant (Ampr), cloning vector for 
N-His constructs with a TEV cleavage site 
Dr. M. Cygler, 
Department of 
Biochemistry, Usask pRL652 Ampr, cloning vector for N-GST 
constructs with a TEV cleavage site 
pHis-GtgE(2-228) Ampr, GtgE(2-228) cloned into pMSCG7 This work 
pHis-GtgE(14-214) Ampr, GtgE(14-214) cloned into pMSCG7 This work 
pHis-GtgE(31-214) Ampr, GtgE(31-214) cloned into pMSCG7 This work 
pGST-GtgE(2-228) Ampr, GtgE(2-228) cloned into pRL652 This work 
pGST-GtgE(14-214) Ampr, GtgE(14-214) cloned into pRL652 This work 
pGST-GtgE(21-214) Ampr, GtgE(21-214) cloned into pRL652 This work 
pGST-GtgE(31-214) Ampr, GtgE(31-214) cloned into pRL652 This work 
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pHis-GtgE(2-228)(C45S) Ampr, pHis-GtgE(2-228) derivative 
containing C45S mutation 
This work 
pHis-GtgE(2-228)(H151S) Ampr, pHis-GtgE(2-228) derivative 
containing H151S mutation 
This work 
pGST-GtgE(14-214)(C45S) Ampr, pGST-GtgE(14-214) derivative 
containing C45S mutation 
This work 
pHis-GtgE(2-228) 
(KNE196ANA) 
Ampr, pHis-GtgE(2-228) derivative 
containing KNE196ANA mutation 
This work 
pHis-GtgE(2-228) 
(KK163AA) 
Ampr, pHis-GtgE(2-228) derivative 
containing KK163AA mutation 
This work 
pECFP-Rab32 Ampr, Rab32 cloned into pECFP-C3 J. Brunell, Department 
of Molecular Genetics, 
University of Toronto 
pGST-Rab32 Ampr, Rab32 cloned into pRL652 This work 
pHis-SpvB(26-355) Ampr, SpvB(26-355) cloned into pMSCG7 Dr. M. Cygler, 
Department of 
Biochemistry, Usask 
pCDNA4TO Ampr, cloning vector for C-HA constructs Wei’s lab 
pSpvB(26-355)-HA Ampr, SpvB(26-355) cloned into 
pCDNA4TO 
This work 
pSpvB(1-591)-HA Ampr, SpvB(1-591) cloned into pCDNA4TO This work 
pSpvB(26-591)-HA Ampr, SpvB(26-591) cloned into 
pCDNA4TO 
This work 
pSpvB(390-591)-HA Ampr, SpvB(390-591) cloned into 
pCDNA4TO 
This work 
pEGFP-N1 Kanamycinresistant (Kanar), cloning vector 
for C-GFP constructs 
Dr. B. Roesler, 
Department of 
Biochemistry, Usask 
pSpvB(1-355)-GFP Kanar, SpvB(1-355) cloned into pEGFP-N1 This work 
pSpvB(1-591)-GFP Kanar, SpvB(1-591) cloned into pEGFP-N1 This work 
pSpvB(26-591)-GFP Kanar, SpvB(26-591) cloned into pEGFP-N1 This work 
pSpvB(390-591)-GFP Kanar, SpvB(390-591) cloned into pEGFP-
N1 
This work 
pFLAG-CTC Ampr, cloning vector for C-FLAG 
constructs 
Dr. A. White, VIDO, 
Saskatoon 
pSpvB(1-591)-Flag Ampr, SpvB(1-591) cloned into pFLAG-
CTC 
This work 
2.2 Structural studies of GtgE 
2.2.1 Constructions of GtgE and Rab32 expression vectors using ligase independent cloning 
(LIC) method 
Target genes (S. Typhimurium GtgE, NCBI reference NP_460029.1 and human Rab32, 
NCBI reference NP_006825.1) were amplified by the polymerase chain reaction (PCR) using the 
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commercial KOD hot start DNA polymerase kit (EMD Millipore, Darmstadt, Germany).  The 
PCR reactions were set up in a 50 µL volume according to the manufacturer’s instructions.  The 
used primers are listed in Table 2-5.  The PCR reaction started with polymerase activation at 
95ºC for 2 min, followed by 25 cycles of denaturing DNA at 95ºC for 20 s, annealing DNA and 
primers at primer denaturing midpoint temperature (normally 57ºC) for 10 s and DNA extension 
at 70ºC  for 20 s/kb.  The amplified DNA product was mixed with DNA loading buffer (Norgen 
Thorold, ON, Canada) and loaded onto 1% (w/v) agarose gel.  The agarose gel was made by heat 
dissolving 1% agarose in 1×TAE buffer, which consists of 40 mM Tris-acetate, pH 8.2-8.4 and 
1 mM ethylenediaminetetraacetic acid (EDTA).  DNA dye, Gelgreen nucleic acid gel stain, was 
added to the mixture at 10,000 times dilution when the agarose mixture cooled down to ~37ºC.  
The gel was cast in a mold with combs to form loading wells.  After loading the samples, 120 V 
was applied to the gel for 30 min and the DNA was visualized under UV light.  The target DNA 
band was excised and purified using the QIAquick Gel Extraction Kit (Qiagen, Valencia, CA, 
USA). 
The vectors of interest (pMSCG7 vector for His-tagged constructs and pRL652 vector for 
GST-tagged constructs) were amplified using vector-specific primers (Table 2-5) in a 50 µL 
reaction system. The PCR was set up in a similar way as described above except the extension 
time at 70ºC was set to 5 min.  The amplified vector DNA products were purified using QIAquick 
Gel Extraction Kit (Qiagen, Valencia, CA, USA) and further treated with DpnI restriction enzyme 
at 37ºC for 1 h to digest the circular template.   
DNA insert was treated with T4 DNA polymerase, which has 3’ to 5’ exonuclease activity, 
in the presence of dCTP to form sticky ends.  The sticky end formation reaction was set up in a 
40 µL reaction volume, which consisted of 200 ng DNA, 1×NEBuffer2, 5 mM dithiothreitol 
(DTT), 1×NEB BSA, 0.3 µL T4 DNA polymerase and 2.5 mM dCTP for treating insert.  To form 
sticky ends, the vector was treated with 2.5 mM dGTP instead of dCTP.  The reaction was set at 
22ºC for 1 h, followed by deactivation enzyme at 75ºC for 20 min. 
T4 DNA polymerase-treated insert DNA and vector were mixed together at a ratio of 
5:1~10:1 in a 10 µL reaction volume to form circular plasmid.  The mixture was incubated at 
room temperature for 1 h.  Subsequently, the DNA mixture was mixed with 50 µL E. coli DH5α 
competent cells and incubated on ice for 20 min.  Afterwards, the competent cells were heat-
shocked at 42ºC for 45 s and cold-shocked on ice for 5 min.  300 µL of antibiotic-free Luria broth 
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media (LB, 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl) was added to the 
mixture, which was further incubated at 37ºC for 40 min.  After the incubation, 100 µL of the 
cell mixture was plated onto LB agar plate (1.5% (w/v) agar in LB medium), which was 
complemented with 100 µg/mL ampicillin.  After 16 h incubation at 37ºC, a single colony was 
picked and grown in LB medium at 37ºCfor 16 h.  The cell culture was spun down at 15,000×g 
for 2 min and used for plasmid extraction using QIAprep Spin Miniprep Kit (Qiagen, Valencia, 
CA, USA).  The sequence of the insert was further confirmed by Sanger sequencing using 
services of the National Research Council (Saskatoon, Canada) or Eurofins (Huntsville, USA). 
 
Table 2-5.  Primers for GtgE and Rab32 constructs using LIC  
 Primer sequence Supplier 
GtgE (F014) TACTTCCAATCCAATGCCAGAAGTAATACAGCAACTCCT
CAGGGT 
IDT 
GtgE (F021) TACTTCCAATCCAATGCCCAGGGTCAGATTATTCACCAT
CGTAAC 
IDT 
GtgE (F031) TACTTCCAATCCAATGCCCAAAGCCAGTTTGATACCACA
GGC 
IDT 
GtgE (R214) TTATCCACTTCCAATGTTACTATTTTGGCTCATAAACACC
GTCATAGTAAAG 
IDT 
Rab32 (F001) TACTTCCAATCCAATGCCATGGCGGGCG IDT 
Rab32 (R225) TTATCCACTTCCAATGTCAGCAACACT IDT 
pMSCG7 F ATTGGAAGTGGATAACGGATCCGAATTCGAGC IDT 
pMSCG7 R ATTGGATTGGAAGTACAGGTTCTCGGTACCCA IDT 
pRL652 F ATTGGAAGTGGATAACGGATCCGAATTCGAGC IDT 
pRL652 R ATTGGATTGGAAGTACAGATTCTCGCTATCCG IDT 
 
2.2.2 Site-directed mutagenesis 
Primers for constructing the desired GtgE mutations are listed in Table 2-6.  The paired 
primers encoding the mutation were used to amplify the plasmid with the gene of interest.  The 
PCR reaction was set up as previously described in the LIC method.  Afterwards, the 50 µL PCR 
product was treated with 1 µL DpnI at 37ºC for 1 h to digest the added template.  Five microliters 
of mixture was transformed into 50 µL DH5α competent cells.  Sequences of the mutants were 
confirmed by Sanger sequencing using services at the National Research Council (Saskatoon, 
Canada) or Eurofins (Huntsville, USA).   
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Table 2-6.  Primers for site-directed mutagenesis for GtgE constructs (F - forward, R - reverse). 
 Primer sequence Supplier 
GtgE(C45A) F GGCAACACCCTCTACAATAATGCCTGGGTTTGC
TCATTAAATG 
IDT 
GtgE(C45A) R CATTTAATGAGCAAACCCAGGCATTATTGTAGA
GGGTGTTGCC 
IDT 
GtgE(C45S) F GGCAACACCCTCTACAATAATAGCTGGGTTTGC
TCATTAAATG 
Eurofins 
GtgE(C45S) R CATTTAATGAGCAAACCCAGCTATTATTGTAGA
GGGTGTTGCC 
Eurofins 
GtgE(H151A) F GCTCGGAATGTCTAAGCTCAGAGTGCATTG IDT 
GtgE(H151A) R CAATGCACTCTGAGCTTAGACATTCCGAGC IDT 
GtgE(H151S) F CTTGGCTCGGAATGTCTAAGCGCAGAGTGCATT
GTAGG 
IDT 
GtgE(H151S) R CCTACAATGCACTCTGCGCTTAGACATTCCGAG
CCAAG 
IDT 
GtgE(H151N) F GCTCGGAATGTCTAAATGCAGAGTGCATTG IDT 
GtgE(H151N) R CAATGCACTCTGCATTTAGACATTCCGAGC IDT 
GtgE(D169A) F GAAGGAAAAAAGTATTAATTTATGCTTCAATGA
ATACCTCACCTGAATGG 
Eurofins 
GtgE(D169A) R CCATTCAGGTGAGGTATTCATTGAAGCATAAAT
TAATACTTTTTTCCTTC 
Eurofins 
GtgE(KK163AA) F GGCTATGATAGTGAAGTGGCAGCAGTATTAATT
TATGATTCAATG 
IDT 
GtgE(KK163AA) R CATTGAATCATAAATTAATACTGCTGCCACTTC
ACTATCATAGCC 
IDT 
GtgE(KNE163ANA) F GCATTCAATGATAAATATGCAAATGCAGATTGC
AGTATTTGTGGTC 
IDT 
GtgE(KNE163ANA) R GACCACAAATACTGCAATCTGCATTTGCATATT
TATCATTGAAGTC 
IDT 
 
2.2.3 Purification and crystallization trials of GtgE constructs 
2.2.3.1 Protein expression 
Plasmids containing the target genes were transformed into E. coli expression cell lines 
(BL21 for GST-tagged protein and BL21(DE3)STAR for His-tagged protein).  A single colony 
was picked and grown at 37ºC for 12-16 h.  The cell culture was scaled up into 1 L terrific broth 
(TB) media (1.2% (w/v) tryptone, 2.4% (w/v) yeast extract, 72 mM K2HPO4, 17 mM KH2PO4, 
and 0.4% (v/v) glycerol).  When the optical density at 600 nm (OD600) reached 0.6, 1 mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to induce expression of the target gene 
and the culture was incubated in the shaker for 12-16 h at 20ºC.   
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2.2.3.2 Purification of the His-tagged GtgE constructs 
Cell cultures expressing His-tagged GtgE were spun down at 7000×g for 20 min.  The 
harvested cells were re-suspended in 50 mL lysis buffer (15 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES) pH 7.5, 150 mM NaCl) and the cells were lysed in a cell 
disrupter (Constant Systems Ltd, TS Series Benchtop).  The cell lysate was centrifuged at 
30,000×g for 45 min.  The supernatant was loaded to nickel-nitrilotriacetic acid (Ni-NTA) 
agarose resin (Qiagen, Valencia, CA, USA).  The Ni2+-charged column was washed with 3 
column volumes of lysis buffer, followed by 2 column volumes of high salt buffer (15 mM 
HEPES pH 7.5, 500 mM NaCl).  Subsequently, the His-tagged protein was eluted by applying 
imidazole gradient.  Column fractions were analyzed by sodium dodecyl sulfate--polyacrylamide 
gel electrophoresis (SDS-PAGE).  Fractions containing the target protein were combined and 
treated with Tobacco Etch Virus (TEV) protease, which is His-tagged, at a 1:50 (w/w) ratio.  The 
cleavage reaction was set up inside a dialysis bag and dialyzed against a buffer containing 15 
mM HEPES pH 7.5, 150 mM NaCl and 1 mM DTT at 4ºC for 16 h.  The treated sample was 
loaded onto a Ni-NTA column to remove un-cleaved His-tagged protein and TEV.  The reaction 
progress was followed by SDS-PAGE.  All the His-tagged GtgE was purified except for His-
GtgE(2-228)(KNE196ANA).  After cell lysis, supernatant was filtered through 0.22 µm filter and 
then applied to a GE pre-packed Hitrap chelating column, which had been charged with Ni2+ and 
equilibrated with lysis buffer, controlled by the NGCTM chromatography Quest 10 plus system 
(Bio-Rad, Mississauga, ON, Canada).  Step gradient of imidazole in buffer was used to elute 
protein.  The TEV protease was also applied to remove the His-tag.  Whenever TEV protease 
was applied to remove the tag, the mixture was loaded onto a Ni2+ column to remove TEV.  
2.2.3.3 Purification of the GST-tagged GtgE constructs 
The cell culture was spun down and the cells were re-suspended in 50 mL lysis buffer (15 
mM HEPES pH 7.5, 150 mM NaCl, 1 mM DTT). The cells were lysed in a cell disrupter, 
centrifuged, and the supernatant was mixed with glutathione (GSH) agarose resin pre-
equilibrated with lysis buffer.  The protein solution and GSH resin was incubated at 4ºC for 1 h 
for binding.  After binding, the resin mixture was loaded into a column with a filter.  The resin 
was washed with 3 column volumes of lysis buffer.  The GST-tagged protein bound to the GSH 
resin was treated with TEV protease in a ~1:50 (w/w) ratio in 10 ml of lysis buffer at room 
temperature for 12 h.  The amount of protein bound to the resin was estimated by measuring the 
  36 
concentration of protein, which was eluted from a fraction of protein-resin mixture using a 20 
mM GSH solution.  After the cleavage reaction, the protein solution was loaded onto a Ni-NTA 
column to remove TEV protease.  Protein fractions were analyzed on SDS-PAGE throughout the 
purification process.  
2.2.3.4 Size exclusion chromatography 
Size exclusion chromatography was the last step in the protein purification protocol.  
Target protein was concentrated to about 5-10 mg/mL and then loaded onto a size exclusion 
Superdex 75 or Superdex 200 column, which was pre-equilibrated with buffer containing 15 mM 
HEPES, 150 mM NaCl and 1 mM DTT.  This buffer was further used to elute protein from the 
column.  Proteins were separated according to their molecular weight.  Protein fractions eluted 
from the column were monitored by measuring the absorption at 280 nm and the peak fractions 
were analyzed by the SDS-PAGE.   
2.2.3.5 SDS-PAGE analysis 
The SDS-PAGE gel is comprised of a stacking gel (at the top) and a separating gel (at the 
bottom).  The extent of separation used in the gel varies from 10 to 15% acrylamide and bis-
acrylamide mixture (29:1), depending on the molecular weight of the protein in question.  For a 
15% gel, the separating gel was composed of 375 mM Tris, pH 8.8, 15% (v/v) acrylamide/bis-
acrylamide (29:1), 0.1% (w/v) SDS, 0.1% (w/v) ammonium persulfate (APS) and 0.1% (v/v) 
N,N,N,N'-tetramethylethane-1,2-diamine (TEMED).  The 5% stacking gel consisted of 125 mM 
Tris, pH 6.8, 5% (v/v) acrylamide/bis-acrylamide (29:1), 0.1% (w/v) SDS, 0.1% (w/v) APS and 
0.1% (v/v) TEMED.  A multi-well comb was inserted into the stacking gel to form multiple lanes 
for loading samples.  Protein samples were loaded into the stacking gel after being mixed with 
loading buffer (62.5 mM Tris, pH 6.8, 2% (w/v) SDS, 0.002% (w/v) bromophenol blue, 100 mM 
DTT, 10% (v/v) glycerol) and denatured at 95ºC for 10 min.  Finally, protein markers were loaded 
on the gel to indicate molecular weight.  The gel was put in the electrophoresis system with ~500 
mL running buffer containing 24.8 mM Tris, 192 mM glycine and 0.1% SDS (w/v).  Then the 
gel was run at 200 V for 55 min.  When the electrophoresis was completed, the gel was removed, 
stained with a solution containing 40% (v/v) ethanol, 10% (v/v) acetic acid and 0.025% (w/v) 
Coomassie brilliant blue R-250 for 20 min, and de-stained with a solution containing 10% acetic 
acid (v/v) and 10% ethanol (v/v) for 30 min.  After destaining, the gel was scanned on an imager 
(Syn-Gene, ChemlXX9).   
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2.2.3.6 Crystallization trials 
GtgE constructs were purified and concentrated to approximately 20 mg/mL. 
Crystallization trials were carried out on GtgE mutants in the absence and presence of peptides 
corresponding to the known Rab32 cleavage site.  The screens were performed in 96-well plates 
in a sitting drop format using the Gryphon crystallization robot (Art Robbins Instruments, 
Sunnyvale, CA, USA).  Micro-batch crystallization approach was also used to set up screens.  
Crystallization screening was performed using both commercial (Hampton Research, Aliso Viejo, 
CA, USA and Qiagen, Valencia, CA, USA) and home-made incomplete factorial screens.  
Promising conditions were explored further by systematic modifications of the initial conditions 
within a narrow range. 
2.2.4 Protease activity of the GtgE constructs 
GST-Rab32 was purified in a similar fashion to GST-tagged GtgE except for omitting the 
GST tag cleavage step.  GST-Rab32 was eluted with 20 mM GSH in buffer containing 15 mM 
HEPES pH 7.5, 150 mM NaCl and 1 mM DTT.  Eluted GST-Rab32 was dialysis against buffer 
containing 15 mM HEPES pH 7.5, 30 mM NaCl and 1 mM DTT at 4ºC for 16-20 h.  After 
dialysis, the protein was loaded onto an anion exchange HitrapQ column, which was pre-
equilibrated with buffer A, composed of 15 mM HEPES pH 7.5 and 1 mM DTT.  After loading 
the protein, the column was washed with 2 column volumes of buffer A.  Protein was eluted with 
a salt step gradient in buffer A, which salt steps of 50 mM, 100 mM, 200 mM, 300 mM, 500 mM 
and 1M NaCl.  Fractions were collected and analyzed by SDS-PAGE. 
GtgE constructs were incubated with GST-Rab32 at 1:2 and 1:20 molar ratio in the 
presence of 10 mM Mg2+ and 10 mM Ca2+.  The reactants were incubated at room temperature 
for 2 h.  An aliquot of the reaction mixture was removed at 1 h.  The reactions were terminated 
by adding SDS-PAGE loading buffer and by denaturing the proteins at 95ºC for 10 min.  The 
sample was analyzed by SDS-PAGE.   
2.2.5 Expression and purification of 15N-GtgE(14-214)(C45S)  
GST-GtgE(14-214)(C45S) was transformed into BL21 for expression, 5 mL LB media 
supplemented with ampicillin was inoculated with a single colony and grown at 37ºC for 16-20 
h.  The overnight cell culture was inoculated into 4 L LB media and incubated at 37ºC in a shaker.  
When an OD600 of the cell culture reached 0.6, cells were harvested using sterilized centrifuged 
tubes at 7000×g for 20 min.  The cell pellet was re-suspended into 1 L M63 washing solution 
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containing 100 mM KH2PO4, 70 mM KOH, 15 mM NH4Cl, 15 mM Na2SO4, 3 µM FeSO4, 18 
µM thiamine, 0.02% (w/v) MgSO4.7H2O and 0.3% glucose.  The mixture was centrifuged at 
7000×g for 20 min and the pellet was resuspended into M63 medium, which contained 15 mM 
15NH4Cl, and supplemented with 50 µg/mL ampicillin.  The cell culture was then induced with 1 
mM IPTG and incubated at 20ºC for 20 h.  The cells were harvested and 15N-GtgE(14-214)(C45S) 
purified in the same way as described for GST-tagged GtgE. 
2.2.6 1H-15N HSQC spectra of 15N-GtgE(14-214)(C45S) and protein titration with peptide 
The 4,4-dimethyl-4-silapentane-1sulfonic acid (DSS) was added to purified 15N-GtgE(14-
214)(C45S) solution to a final concentration of 1 mM.  D2O was added into protein mixture to a 
final concentration of 10%.  The 1H-15N heteronuclear single quantum correlation (HSQC) 
spectrum was recorded at 298 K on a Bruker NMR spectrometer operating at 600 MHz frequency.  
After recording the protein spectrum, a 5-fold excess of peptide (RATIGVDFALK) was added 
to the protein solution and a second spectrum was recorded.  The NMR data acquisition was 
performed by Mr. Corey Yu, Department of Biochemistry, University of Saskatchewan (Dr. Oleg 
Dmitriev’s laboratory).  
2.2.7 Nanopore analysis of GtgE constructs 
The lipid, 2-dipheytanoyl-sn-glycero-3-phosphocholine, was dissolved in chloroform, 
dried under vacuum condition for 4 h and redissolved in decane to a final concentration of 30 
mg/mL (Stefureac et al., 2006).  The lipid solution was painted onto the aperture in a Teflon 
perfusion cup to form lipid bilayer.  1 mL of buffer solution containing 10 mM HEPES, pH 7.8 
and 1 M KCl was added onto both the cis and trans compartments of the cup.  Alpha-hemolysin, 
which is a protein used for pore formation, was added into the cis compartment in the cup at a 
concentration of 1.25 µg/mL.  A direct current potential of 100 mV was applied to insert α-
hemolysin into the lipid to form a stable pore.  The protein of interest (GtgE constructs) at a final 
concentration of 1 µM was added into the cis compartment of the cup.  A 100 mV potential was 
applied to the cup and the signals were recorded with a computer running PClamp 10.1 program 
(Axon Instruments, Molecular Devices, Sunnyvale, CA, USA).  The data was processed with the 
programs Clampfit 10.1 (Axon Instruments) and Origin 7.0 (Meller and Branton, 2002).  The 
blockade current histograms peaks were obtained by fitting the blockade current distribution with 
a Gaussian function.  The lifetime curve was obtained by fitting each blockade time distribution 
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with a single-exponential function.  The nanopore experiments were performed by Ms. Elisabet 
Jakova, Department of Biochemistry, University of Saskatchewan (Dr. Jeremy Lee’s laboratory).  
2.3 Structure determination of SpvB(26-355) 
2.3.1 Purification and methylation of SpvB(26-355) 
His-SpvB(26-355) expression plasmid was constructed by Ms. Linhua Zhang (Dr. Cygler’s 
laboratory).  The plasmid was transformed into the BL21(DE3)STAR cell line.  The protein was 
expressed and harvested as described above.  The cells were resuspended in 50 mL lysis buffer 
(15 mM HEPES pH 7.5, 200 mM NaCl) supplemented with protease inhibitors cocktail.  The 
protein was purified in a similar manner as described for His-GtgE.  The protein was treated with 
TEV protease at 1:50 (w/w) ratio and dialyzed against 15 mM HEPES pH 7.5, 200 mM NaCl 
and 1 mM DTT buffer at 4ºC for 16 h to remove the His-tag.  The protein mixture was 
subsequently loaded on a Ni-NTA column to remove the uncleaved His-SpvB(26-355) and TEV, 
which also contained a His tag at the N-terminus.  SDS-PAGE analysis was used to follow the 
reaction progress.   
SpvB(26-355) was methylated using formaldehyde and dimethylamine borane complex.  20 
µL of 1.0 M dimethylamine borane solution was added to 1.0 mL containing 10 mg/mL protein 
in HEPES pH 7.5.  Subsequently 40 µL of 1.0 M formaldehyde was added to the solution.  After 
2h incubation at 4ºC an additional 20 µL of 1.0 M dimethylamine borane solution and 40 µL of 
1.0 M formaldehyde were added.  After another 2h incubation at 4ºC 10 µL of 1.0 M 
dimethylamine borane was added to the mixture and incubated at 4ºC overnight.  Afterward, 125 
µL of 1.0 M glycine and 125 µL of 50 mM DTT were added to stop the reaction.  The mixture 
was incubated at 4ºC for 2 h.  When the reaction was completed, the mixture was dialyzed at 4ºC 
for 12 h against buffer containing 15 mM HEPES pH 7.5, 200 mM NaCl and 1mM DTT.  Dialysis 
buffer was changed once after 2 h.  The methylated protein was concentrated using a Milipore 
concentration tube (30K cut-off).  Protein concentration was measured using absorption at 280 
nm and the protein extinction coefficient (65320 M-1 cm-1) was calculated using the ProtParam 
server (http://web.expasy.org/protparam/).   
2.3.2 Crystallization, X-ray diffraction and data collection of SpvB(26-355) 
Methylated SpvB(26-355) was concentrated to 10 mg/mL.  Initial screening was performed 
using commercial incomplete screens by the application of a sitting drop vapor diffusion method.  
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Crystallization plates were set up using Gryphon robot.  Initial crystallization conditions were 
optimized by fine-tuning protein concentration, pH, precipitant concentration, additive 
concentrations, size of the drop and the crystallization temperature.  The best crystal were 
obtained from well solution containing 0.1 M Bis-Tris pH 6.5, 14% poly(acrylic acid) 5100 
sodium, 4% PEG3350, 1 mM DTT and 20 mM MgCl2.  These crystals belong to the space group 
of P43212 with cell dimensions of 101.4, 101.4, 211.3 Å and contain 2 molecules in the 
asymmetric unit, corresponding to Vm =3.61 Å3/Da and solvent content of 66%.  Crystals were 
mounted within a fiber loop, transferred into the cryo-protectant solution containing mother 
liquor supplemented with 20% glycerol, and flash-cooled in liquid nitrogen.  Diffraction data 
were collected from a single crystal at the 08ID beamline, Canadian Light Source (CLS) equipped 
with a CCD X-ray detector and controlled by the CLS MXDC software.  The crystal-to-detector 
distance was set at 300 mm.  The oscillation range was 1° per frame and 180 frames were 
collected.  The frames were indexed, integrated and scaled using the HKL3000 software package 
(Minor et al., 2006).  
2.3.3 Structure determination of SpvB(26-355) 
The structure was solved by molecular replacement method using the Phaser-MR 
program (McCoy et al., 2007) within the PHENIX package (Adams et al., 2010).  The search 
model consists of residues 28 to 366 of YenB from Yersinia Entomophaga ABC toxin (PDB 
entry 4IGL).  The sequence identity between the search model and SpvB(26-355) is 47%.  Two 
molecules were identified in the asymmetric unit.  The initial R-factor for the molecular 
replacement solution was 0.263.  Refinement of the model was carried out in Phenix.refine 
(Adams et al., 2010) and manual rebuilding was performed with the program Coot (Emsley et 
al., 2010b).  Five percent of randomly selected reflections were set aside for monitoring Rfree.  
The final model comprise residue 34-353 in chain A and chain B.  There was not interpretable 
electron density for residue 26-33 and 353-354 in both chains.  The final R-factors: Rwork=0.200 
and Rfree=0.239.  
2.4 Functional studies of SpvB(26-355) 
2.4.1 Construction of SpvB-HA 
The inserted gene was amplified and purified the same way as previously described and 
inserted into the pCDNA4TO vector.  The primers for the restriction enzyme digestion cloning 
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method are listed in Table 2-7.  The DNA insert and the pCDNA4TO vector were digested with 
restriction enzymes in 50 µL reaction volume, which consisted of 1×NEB buffer 3.1, 200 ng 
DNA, 1 µL each of two restriction enzymes PstI and XhoI.  The digestion reactions were set at 
37ºC for 2 h.  After digestion DNA was loaded on 1% agarose gel.  The target DNA-containing 
band was cut out and the DNA was purified using QIAquick gel extraction kit.  Subsequently, 
insert DNA and vector were mixed at a 5:1~10:1 ratio in 20 µL reaction volume containing 1 µL 
T4 DNA ligase and supplemented buffer.  The mixture was incubated at room temperature for 1 
h.  After ligation, 5 µL of the mixture was used for transformation of 50 µL DH5α competent 
cells.  Correct sequences of targets were confirmed by Sanger sequencing.   
 
Table 2-7.  Primers for SpvB constructs used for restriction enzyme digestion cloning method 
 Primer sequence Restriction 
enzyme 
Supplier 
SpvBPstI (F001) TCCAATCTGCAGCCATGTTGATACTAAAT
GGTTT 
PstI IDT 
SpvBPstI (F026) ATCTGCAGCCGCGCTGAGTCAGTCAGGC
CCT 
PstI IDT 
SpvBPstI (F390) AATGGGCTGCAGTAGAGGAATCAAAGCA
GATTCA 
PstI IDT 
SpvBXhoI (R355) CTTCCACTCGAGGTCGCCTTCATAGGCCA
GCGT 
XhoI IDT 
SpvBXhoI (R591) CTTCCACTCGAGCTATGAGTTGAGTACCC
TCAT 
XhoI IDT 
The recognition sites for the restriction enzymes were underlined.  
2.4.2 Co-immunoprecipitation (Co-IP) of SpvB constructs with actin 
2.4.2.1 Transfection of mammalian cells 
Mammalian cells (HeLa or HEK293) were recovered from the -80ºC freezer on OPTI-
MEM medium and incubated in a humidified CO2 incubator (Thermo Fisher Scientific, 
HERAcell 150i) with 5% CO2 at 37ºC for 24 h.  4 µg of plasmids were added to 1 mL of OPTI-
MEM medium and the mixture was incubated at 37ºC for 20 min.  Eight microliters of 
XtremeGENE HP DNA Transfetion reagent was added into the mixture, which then was added 
to cell culture.  Cell culture containing plasmid was further incubated at 37ºC for 24 h for 
overexpression.   
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2.4.2.2 Co-IP using anti-HA antibody 
After transfection with plasmids for 24 to 48 h, the medium was aspirated and the cells 
were washed with the phosphate buffered saline (PBS), which consisted of 10 mM phosphate pH 
7.4, 137 mM NaCl and 2.7 mM KCl.  Cells were detached by treating them with 0.25% (w/v) 
trypsin at 37ºC for 3 min and the reaction was terminated with 2 mL 10% fetal bovine serum 
(FBS).  Subsequently, cells were dispersed and transferred to a clean 15 mL falcon tube.  Cells 
still remaining in the plate were washed by adding 2 mL 10% FBS and the solution was added to 
the falcon tube.  The mixture was spun down at 1500×g at 4ºC for 5 min.  The cells were 
resuspended in 750 µL of ice-cold PBS and transferred to a 1.5 mL Eppendorf tube.  Another 
500 µL ice-cold PBS was added to the falcon tube and transferred to the same Eppendorf tube.  
The cells were spun down at 5000×g at 4ºC for 1 min.  The cells were re-suspended in 3 times 
their volume in ice-cold lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1 mM EDTA, 1% (v/v) 
Nonidet P-40, 10% (v/v) glycerol, 1×protease inhibitor cocktail and 200 mM PMSF).  After 
incubation on ice for 30 min, the cell mixture was centrifuged at 15,000×g at 4ºC for 15 min.  
The supernatant was carefully transferred to another 1.5 mL Eppendorf tube. Protein 
concentration was measured using the Bradford method.  Part of the lysate was saved for running 
the Western blot.  The rest of the cell lysate was mixed with mouse anti-HA antibody (0.2 µg/µL) 
and 25 µL Protein G agarose resin, which was pre-equilibrated with lysis buffer.  After incubation 
at 4ºC for 16 h the mixture was centrifuged at 3000×g for 1 min and the supernatant was 
transferred to another clean 1.5 mL tube.  The resin was washed with 1 mL lysis buffer 3 times 
for 5 min each and re-suspended in 60 µL lysis buffer.  Finally, 20 µL of 4×SDS-PAGE loading 
buffer was added to the resin.  The sample was denatured at 95ºC for 10 min.   
2.4.2.3 Western blot for detecting SpvB and actin 
An SDS-PAGE gel containing target samples (equal amount) and a positive control was 
washed with double distilled H2O (ddH2O) and then with the transfer buffer (1.0 L transfer buffer 
consisted of 2.9 g glycine, 5.8 g Tris, 0.37 g SDS and 200 mL methanol).  A sandwich was 
assembled with the filter paper (pre-soaked with transfer buffer) at the bottom, polyvinylidene 
fluoride (PVDF) membrane (pre-soaked in methanol for 5 min and washed with transfer buffer), 
SDS-PAGE gel, and another filter paper (pre-soaked with transfer buffer) on the top.  Air bubbles 
inside the sandwich were carefully removed.  The sandwich was then placed in a semi-dry 
transferring apparatus (Bio-Rad, 170-3940).  The transferring process was set at constant 
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amperage of 0.1 A for 1 h.  After transferring protein from the gel to the membrane, the membrane 
was removed from the apparatus and washed with PBST (0.1% (v/v) Tween-20 in PBS).  
Blocking solution (5% (w/v) of skim milk in PBST) was applied to the membrane at room 
temperature for 1 h.  The blocking solution was aspirated, the primary mouse anti-HA antibody 
in blocking solution was applied and the membrane was incubated at room temperature for 1 h 
or at 4ºC overnight.  The membrane was then washed with PBST three times for 10 min each 
time.  The secondary goat anti-mouse-IgG antibody conjugated with horseradish peroxidase 
(HRP) in blocking solution was applied to the membrane at room temperature for 1 h.  
Subsequently, the membrane was washed three times for 10 min with PBST.  The membrane was 
covered with ECL reagent mixture (GE healthcare, RPN2109) (HPR substrate) and after 1 min 
incubation the membrane was overlaid on an X-ray film, which was later developed using X-ray 
Film Processor (PROTECT Processor Technology, OPTIMAX).   
2.4.3 Localization of SpvB constructs 
In order to test the secretion of SpvB in Salmonella, different SpvB truncations, spvB(1-591), 
spvB(1-355), spvB(390-591) were inserted into the pEGFP-N1 vector (provided by Dr. Bill Roesler, 
Department of Biochemistry, University of Saskatchewan), which was used to express protein 
with a GFP-tag fused at the C-terminus.  Primers needed for construction are listed in Table 2-8.  
The constructs were completed by the same approach as described above to make HA tagged 
constructs.  The EAE536AAA mutants were made to inactivate the ADP-ribosyltransferase 
activity of SpvB.  Site directed mutagenesis was performed by the same method as described 
above for mutating GtgE. 
Cells were plated on glass coverslips, which were placed at the bottom of the six-well 
plates.  After transfection with SpvB plasmids, the cultures were aspirated and the cells were 
washed with PBS.  Hereafter, the cells were covered with aluminum foil to avoid lights.  Each 
well was supplemented with 4% (w/v) of paraformaldehyde and incubated for 30 min at room 
temperature to fix the cells.  Cells were washed three times for 10 min with PBST.  After fixation, 
the cells were washed with 0.5% (v/v) Triton-X100 in PBST for 5 min, followed by another wash 
with PBST for 10 min.  Subsequently, the cells were blocked with 5% FBS for 30 min at room 
temperature.  When blocking was completed, the cells were incubated with 0.5 µM 4',6-
diamidino-2-phenylindole (DAPI) and 0.1 µM Acti-stain 555 phalloidin (Cytoskeleton, PHDH1-
A) at room temperature for 30 min.  The cells were washed three times for 10 min with PBST.  
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The coverslips carrying the cells were fixed and sealed on glass plates.  The slides were imaged 
under confocal laser fluorescent microscope (Zeiss LSM 510 Meta, Zeiss).   
 
Table 2-8.  Primers for the GFP-tagged SpvB constructs 
 Primer sequence Enzyme Supplier 
SpvBXhoI (F001) AATTCTCTCGAGATGTTGATACTAAA
TGGTTT 
XhoI Eurofin 
SpvBXhoI (F026) TGGAATCTCGAGATGGCGCTGAGTCA
GTCAGGCCCT 
XhoI Eurofin 
SpvBXhoI (F390) TGGAATCTCGAGATGGAGGAATCAA
AGCAGATTCA 
XhoI Eurofin 
SpvBEcoRI (R355) TCTAGAGAATCCGGTCGCCTTCATAG
GCCAGCGT 
EcoRI Eurofin 
SpvBEcoRI (R591) AGACTCGAATCCGTGAGTTGAGTACC
CTCATGTT 
EcoRI Eurofin 
Primer for mutation 
SpvB(EAE536AAA) F GTTGCACATTTTAAGGGAGCGGCAGC
GATGCTTTTCCC 
N.A Eurofin 
SpvB(EAE536AAA) R GGGAAAAGCATCGCTGCCGCTCCCTT
AAAATGTGCAAC 
N.A Eurofin 
 
2.4.4 Cytotoxicity of SpvB constructs in the host cells 
HeLa cells were transfected with pEGFP-N1, pSpvB(1-591)-GFP, pSpvB(1-355)-GFP and 
pSpvB(390-591)-GFP.  After transfection for 24 h, cells were harvested as described above.  The 
lactate dehydrogenase (LDH) activity in the cells transfected with different constructs was 
measured following the protocol of a lactate dehydrogenase activity assay kit (Sigma, MAK066).  
At least three dilutions of all the samples were measured with the kit and each measurement was 
in duplicate.  The experiments were repeated three times.   
2.4.5 Secretion of SpvB(1-591)-Flag in wild-type and mutant Salmonella 
In order to test the secretion of SpvB in Salmonella, spvB(1-591) was inserted into pFLAG-
CTC vector (provided by Dr. Aron White, Vaccine and Infectious Disease Organization, 
Saskatoon), which was used to express proteins with a Flag-tag fused at the C-terminus.  The 
primers used are listed in Table 2-9.  The construction of the plasmid was similar to the 
construction of the HA-tagged SpvB except for the application of different restriction enzymes. 
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Table 2-9.  Primers for construction of SpvB(1-591)-Flag 
 Primer sequence Restriction 
enzyme 
Supplier 
SpvBXhoI(F001) AATTCTCTCGAGATGTTGATACTAAATG
GTTT 
XhoI Eurofin 
SpvBBglII(R591) GCGAGAAGATCTTGAGTTGAGTACCCTC
ATGTT 
BglII Eurofin 
The recognition site of the restriction enzymes are underlined.  
 
The plasmids were transformed into wild-type S. Enteritis strain 18 to express SpvB(1-591)-
Flag.  The bacteria were first grown overnight in the LB medium and 2 mL of this cell culture 
was used to inoculate 300 mL fresh LB medium, which was then incubated in a shaker at 37ºC 
until OD600 reached 0.7.  To stimulate SPI-1 secretion system, 1.7 mL of overnight cell culture 
was inoculated into 250 mL LB-0.3 M NaCl medium at 1:150 ratio and grew at 37ºC incubator 
under static anaerobic conditions for 16 h.  To stimulate SPI-2 system, 10 mL of the overnight 
cell culture was spun down and the pellet was resuspended in 500 mL low pH medium (LPM), 
which consisted of 337 mM phosphate buffer, 5 mM KCl, 7.5 mM (NH4)2SO4, 0.5 mM K2SO4, 
0.1% (w/v) casamino acids, 38 mM glycerol, 8 µM MgCl2, and pH adjusted to 5.8 by using 80 
mM MES.  This culture grew in a shaker at 37ºC for 16-18 h and then induced with 1 mM IPTG 
for 2 h.   
All cell cultures were centrifuged at 8000×g for 30 min.  The supernatants were filtered 
with 0.22 µm polyethersulfone (PES) membrane to remove the remaining bacteria from the 
supernatants.  Trichloroacetic acid (TCA) was added to the filtered supernatant to a final 
concentration of 15% (w/v) in order to precipitate proteins.  The mixture was incubated at -20ºC 
for 30 min and further incubated at 4ºC for 16-20 h.  Subsequently, the mixture was centrifuged 
at 10,000×g for 30-60 min.  The TCA supernatant was discarded and the protein pellet was 
washed with ice-cold acetone.  After drying the acetone, PBS buffer was added to dissolve the 
remaining proteins.  The protein samples were prepared for Western blotting.  Anti-Flag antibody 
was used to detect the expression of SpvB-Flag.  To demonstrate that the presence of SpvB in 
the medium was not due to cell leakage, a cytosolic heat shock protein DnaK was used as a 
control.  To confirm that the TTSS was fully functional, anti-SopE2 serum was used to detect 
SopE2, a SPI-1 effector, and anti-SseL serum for SseL, a SPI-2 substrate.   
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Western blots were performed in a similar way as described above except for: (1) using 
nitrocellulose membrane instead of PVDF membrane for protein support, (2) using alkaline 
phosphatase conjugated secondary antibody instead of using HRP conjugated secondary antibody 
and (3) using Nitroblue tetrazolium/ 5-bromo-4-chloro-indolyl phosphate (BNT/BCIP) substrate 
solution instead of ECL substrates to detect secondary antibody.   
The plasmid carrying spvB(1-591) was also transformed into a Salmonella Δspi-1 mutant 
strain, Δspi-2 mutant strain and Δspi-1&2 mutant strain.  The Δspi-1 mutant harboring SpvB was 
grown in the SPI-2 stimulating medium; Δspi-2 mutant was grown in the SPI-1 stimulating 
medium and Δspi-1&2 mutant was grown in LB medium in the same way as described above.  
Proteins were precipitated as described above.  The presence of proteins was detected by Western 
blot as described above. 
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3. Results 
3.1 Structural studies of GtgE 
3.1.1 Purification and crystallization trials of GtgE(2-228)  
His- and GST-tagged constructs of GtgE(2-228) were made as a part of high-throughput 
cloning of bacterial effectors (Linhua Zhang, Dr. Cygler laboratory).  His-GtgE(2-228) was highly 
expressed and was purified using Ni-NTA affinity chromatography.  The His-tag was removed 
by digestion with TEV protease.  The digest was loaded again on the Ni-NTA column to remove 
any remaining His-GtgE as well as the His-tagged TEV protease.  Subsequently, GtgE-containing 
fractions were loaded on a Superdex75 size exclusion chromatography column.  Eluted fractions 
were analyzed by SDS-PAGE (Fig. 3-1) and the GtgE-containing fractions were pooled together.  
Similarly, GST-GtgE(2-228) was loaded on the glutathione agarose resin and the tag was cleaved 
on the column by adding TEV protease and incubating for 16 h.  The GtgE protein was eluted 
from the column in the wash step and was further purified on a Superdex 200 gel filtration column.  
The quality of the protein sample was assessed by dynamic light scattering for the homogeneity 
of the protein in solution.  Light scattering shows monodisperse molecular behavior when the 
particles/protein in solution are uniform.  When the particles form various multimers or 
aggregates, the dynamic light scattering shows a polydisperse behavior.  Monodispersity 
correlates with the propensity of protein to crystallize (Ferré-D'Amaré and Burley, 1994).  The 
protein sample was concentrated to ~20 mg/mL and subjected to crystallization screening in a 
sitting drop format using multiple commercial screens.  The screens were set up using the 
Gryphon Crystallization Robot.  Crystallization trials were carried out at room temperature and 
at 4ºC.  Despite screening nearly one thousand conditions, no crystals were formed.  In an effort 
to facilitate crystallization, GtgE was methylated; the chemical methylation of accessible lysines 
alters the surface properties of a protein.  These changes can make a protein more likely to 
crystallize.  Unfortunately, methylated GtgE did not yield any crystals either.  
3.1.2 Mutation of the active site His151 
GtgE was shown to be a cysteine protease containing a Cys-His-Asp triad (Spano et al., 
2011; Spanò and Galán, 2012; Kohler et al., 2014).  The critical base was identified as H151 
(Spano et al., 2011).  I mutated this His151 to Ala (H151A), Ser (H151S) or Asn (H151N) to 
render the protein inactive.  I reasoned that a loss of catalytic activity would allow for co-
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crystallization of GtgE with peptide substrates.  Interestingly, of the three mutants only H151S 
was soluble.  GST-GtgE(2-228)(H151S) was purified and the tag removed as described above for 
the wild type protein (Fig. 3-2).  This protein was used for more crystallization trials, albeit 
without success. 
 
Fig. 3-1.  Expression and purification results for the His-GtgE(2-228) construct.  A. The SDS-PAGE 
gel showing fractions collected during affinity purification of His-GtgE(2-228) using Ni-NTA resin.  
Lane 1: protein markers, 2: content of the protein pellet, 3: supernatant, 4: proteins not retained 
on the resin, 5: proteins washed away with the lysis buffer, 6: protein eluted with 10 mM 
imidazole, 7: protein eluted with 200 mM imidazole, 8: protein eluted with 400 mM imidazole, 
9: proteins retained on the column, 10: cleavage the His tag with TEV protease.  B. Elution profile 
of affinity purified GtgE(2-228) on the Superdex 200 size exclusion column.  The insert shows the 
SDS-PAGE gel of fractions across the main peak.   
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 Fig. 3-2.  Expression and purification results for the GST-GtgE(2-228)(H151S) construct.  A. The 
SDS-PAGE gel showing fractions progress of affinity purification of GST-GtgE(2-228)(H151S) on 
Glutathione (GSH) agarose resin.  Lane 1: content of the protein pellet, 2: supernatant, 3: proteins 
not retained on the resin, 4: proteins washed away with lysis buffer, 5: protein bound to resin, 6: 
untagged proteins after TEV cleavage, 7: protein markers.  B. Elution profile of the affinity 
purified GtgE(2-228)(H151S) from the Superdex 75 size exclusion column.  The insert shows the 
SDS-PAGE gel of fractions from the largest peak.   
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3.1.3 Protease activity assay for GtgE(2-228) and GtgE(2-228)(H151S) 
To test the activity of the recombinant His-GtgE(2-228) and GtgE(2-228)(H151S), GST-
Rab32 was used as the GtgE substrate.  GST-Rab32 was purified using glutathione resin and 
further purified through an anion exchange chromatography (Fig. 3-3).  The cleavage of Rab32 
was analyzed by SDS-PAGE.  According to literature, the cleavage occurs after Gly59 (Spanò 
and Galán, 2012).  The GST tag was fused to the N-terminus of Rab32.  Thus, after the cleavage 
by GtgE, a ~35 kDa fragment should be detected.   
GST-Rab32 was treated with His-GtgE(2-228) and GtgE(2-228)(H151S) at 2:1 (GST-
Rab32:GtgE) and 20:1 molar ratio in the presence of Mg2+ and Ca2+ at room temperature.  To 
exclude the spontaneous degradation of proteins, GST-Rab32 without GtgE proteins were treated 
the same way as a negative control.  Samples were aliquoted and the reactions were determined 
by adding SDS-PAGE loading buffer and denaturing the samples at 95ºC for 10 min.  These 
samples were analyzed on an SDS-AGE gel.  A 35 kDa band increased in intensity with the 
treatment of His-GtgE(2-228), which indicated activity of His-GtgE(2-228), albeit the  activity was 
relatively low.  This was evidenced by the detection of uncleaved substrate 2 h after the onset of 
the reaction at room temperature.   
The protease activity of GtgE(2-228)(H151S) was tested.  A new batch of the GST-Rab32 
substrate was used.  This preparation of Rab32 was less pure and contained a band with molecular 
weight similar to the expected cleavage fragment.  No change in intensity of the 35 kDa band 
was observed, nor the decrease in the amount of the intact substrate.  This result confirmed that 
the GtgE(2-228)(H151S) was indeed inactive  
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Fig. 3-3.  Expression and purification of the GST-Rab32 construct.  A. SDS-PAGE gel showing 
fractions collected during affinity purification of GST-Rab32 using GSH resin.  Lane 1: protein 
markers, 2: content of the protein pellet, 3: supernatant, 4: proteins not retained on the affinity 
column, 5: proteins washed away with lysis buffer, 6: protein eluted with 20 mM GSH, 7: protein 
eluted with 30 mM GSH, 8: protein retained on the resin.  B. SDS-PAGE showing fractions 
collected from an anion exchange HitrapQ column.  Lane 1: Affinity purified sample loaded to 
HitrapQ column, 2: proteins eluted with buffer containing of 15 mM HEPES and 1 mM DTT , 3: 
proteins eluted with the buffer in addition of 50 mM NaCl, 4: proteins eluted with the buffer in 
addition of 100 mM NaCl, 5: proteins eluted with the buffer in addition of 200 mM NaCl, 6: 
proteins eluted with the buffer in addition of 300 mM NaCl, lane 7: proteins eluted with the buffer 
in addition of 500 mM NaCl, 8: proteins eluted with the buffer in addition of 1 M NaCl, 9: protein 
marker.  GST-Rab32 from B. lane 5 was used as substrate for testing GtgE activity.  
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Fig. 3-4.  Determination of protease activity of His-GtgE(2-228) and GtgE(2-228)(H151S) using GST-
Rab32 as a substrate.  The reaction was performed at room temperature.  A. The activity of His-
GtgE(2-228) based on SDS-PAGE gel result.  Lane 1: protein markers, 2: GST-Rab32 substrate to 
control after 1 h, 3: Cleavage of GST-Rab32 by His-GtgE(2-228) in 2:1 (substrate : enzyme) in 
molar ratio after 1 h incubation, 4: Cleavage of GST-Rab32 by His-GtgE(2-228) in 20:1 ratio for 1 
h, 5: GST-Rab32 substrate to control after 2 h, 6, Cleavage of GST-Rab32 by His-GtgE(2-228) in 
2:1 ratio for 2 h, 7: Cleavage of GST-Rab32 by His-GtgE(2-228) in 20:1 ratio for 2 h incubation.  
B. The activity of His-GtgE(2-228)(H151S) based on SDS-PAGE gel result.  The substrate was 
purified from a new batch substrate (which contains some impurities).  The pre-existed band with 
the * mark had the similar molecular weight to the expected product fragment of Rab32 during 
cleavage by GtgE.  Lane 1: GST-Rab32 substrate to control after 1 h, 2: Cleavage of GST-Rab32 
by GtgE(2-228)(H151S) in 2:1 ratio after 1 h incubation, 3: Cleavage of GST-Rab32 by GtgE(2-
228)(H151S) in 20:1 ratio for 1 h, 4: GST-Rab32 substrate to control after 2 h, 5: Cleavage of GST-
Rab32 by GtgE(2-228)(H151S) in 2:1 ratio for 2 h, 6: Cleavage of GST-Rab32 by GtgE(2-
228)(H151S) in 20:1 ratio for 2 h incubation, 7: protein markers.   
 
3.1.4 Purification and crystallization trials of entropy-reduced surface mutants of GtgE 
Another rescue strategy employed in crystallization of ‘difficult’ proteins is to mutate a 
cluster of large, flexible sidechain residues on the protein surface into smaller residues to reduce 
protein entropy (Derewenda, 2004).  Two promising mutations, KK161AA and KNE196ANA, 
predicted by the SERp sever (http://services.mbi.ucla.edu/SER/) were introduced into the His-
GtgE(2-228) construct.  The expression level of His-GtgE(2-228)(KK163AA) was very low but His-
GtgE(2-228)(KNE196ANA) expressed well.  His-GtgE(2-228)(KNE196ANA) was purified using Ni-
NTA affinity column (Fig. 3-5.A).  Fractions containing target protein was subjected to TEV 
  53 
cleavage to remove the His-tag (Fig. 3-5.B).  This purified protein was also used for 
crystallization screening, albeit without success. 
 
 
Fig. 3-5.  Purification results for the His-GtgE(2-228)(KNE196ANA) construct.  A. Elution profile 
of His-GtgE(2-228)(KNE196ANA) from Ni-NTA column using imidazole step gradient.  The blue 
curve shows absorption at 280 nm and the orange shows the imidazole concentration.  The inserts 
show SDS-PAGE gels of the fractions across the peaks.  B. Cleavage of the His-tag from the 
construct by TEV protease.  Lane 1: protein markers, 2: His-tagged protein. 3: untagged protein.   
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3.1.5 New GST-tagged constructs, GtgE(14-214), GtgE(21-214) and GtgE(31-214) 
While this research was in progress, the structure of the inactive GtgE(80-213) fragment  has 
been published (Kohler et al., 2014).  This structure, which contains only residues 80 to 213, 
suggests that the N- and C-terminal regions are hampering crystallization of the full length protein.  
The active site Cys45 is not part of the crystallized fragment.  In order to probe if a longer 
construct containing this cysteine could still be crystallized, I designed several new constructs 
guided by the disorder prediction (Fig. 3-6) and the secondary structure prediction (Fig. 3-7).   
The GST-GtgE(14-214), GST-GtgE(21-214) and GST-GtgE(31-214) constructs were made.  
Hereafter, all the described GtgE constructs were expressed as a GST fusion with a cleavable 
GST tag.  GST-GtgE(14-214) and GST-GtgE(31-214) expressed as soluble proteins with a good yield, 
while GST-GtgE(21-214) was insoluble.  Untagged GtgE(14-214) (Fig. 3-8) and GtgE(31-214) (Fig. 3-9) 
were purified to near homogeneity by the methods described above and were concentrated to ~25 
mg/mL.  These two proteins were used in crystallization trials at 4ºC and at room temperature.  
In addition, methylation was carried out for both proteins, but no crystals were observed.   
 
Fig. 3-6.  The intrinsic disorder profile of GtgE.  The prediction was performed by the 
DISOPRED3 predictor (http://bioinf.cs.ucl.ac.uk/psipred/).  The blue line indicates the 
disordered state.  Amino acid residues with the confidence score higher than 0.5 are considered 
as disordered.   
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Fig. 3-7.  Secondary structure prediction of GtgE.  The prediction was performed by the Psipred 
protein sequence analysis workbench (http://bioinf.cs.ucl.ac.uk/psipred/).  The label on the left 
side are Conf, which indicates the confidence of prediction, Pred, which shows the predicted 
secondary structure, and AA, which is the target sequence.  The secondary structure prediction 
presents in two ways: one using a pink cylinders for a representing α-helix, a yellow arrow for β-
strand and a black line for a coil and the other one using letters, C for coil, H for helix and E for 
strand. 
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Fig. 3-8. Expression and purification results for the GST-GtgE(14-214).  A. The SDS-PGAE gel 
showing fractions collected while purifying GST-GtgE(14-214) on a GSH resin.  Lane 1: protein 
markers, 2: content of the protein pellets, 3: supernatant, 4: proteins not retained on the resin, 
lane 5: protein retained to the resin.  B. SDS-PGAE gel showing the GST-tag cleavage result by 
TEV protease.  TEV protease was added to the protein bound resin at an approximate ratio 1:50 
(TEV:substrate).  Lane 1: protein markers, 2: protein not retained on the resin after cleavage, 3: 
proteins retained on the GSH resin after cleavage.  C. The elution profile of affinity purified 
GtgE(14-214) from the Superdex 75 size exclusion column.  The insert shows the SDS-PAGE gel 
of fractions from the largest peak.   
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Fig. 3-9.  Purification results for the GST-GtgE(31-214) construct.  A. The SDS-PGAE gel showing 
fractions collected while purifying GST-GtgE(31-214) on a GSH resin.  Lane 1: protein markers, 2: 
supernatant, 3: proteins not retained on the resin, 4: protein retained to the resin.  B. The SDS-
PGAE gel showing the GST-tag cleavage by TEV protease.  Lane 1: protein markers, 2: protein 
not retained on the resin after cleavage, 3: proteins retained on the GSH resin after cleavage.  C. 
Elution profile of the affinity purified GtgE(31-214) from the Superdex 75 size exclusion column.  
The insert shows the SDS-PAGE gel of fractions from the largest peak.   
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3.1.6 Protease activity assay for GtgE(14-214) and GtgE(31-214)  
The proteolytic activity of GtgE(14-214) and GtgE(31-214) was tested with GST-Rab32 as a 
substrate.  His-GtgE(2-228) was used as a positive control and GtgE(2-228)(H151S) as a negative 
control in the protease activity assay.  GST-Rab32 was treated with GtgE(14-214) and GtgE(31-214) 
in the molar ratio of 2:1 (GST-Rab32:GtgE) and 20:1 in the presence of Mg2+ and Ca2+.  The 
reactions were performed at room temperature.  After the reaction, protein samples were loaded 
on an SDS-PAGE gel to visualize the cleavage of GST-Rab32.  The 35 kDa band increases in 
intensity upon treatment with GtgE(14-214) (Fig. 3-10).  Conversely, no such increase was observed 
in the sample treated with inactive GtgE(2-228)(H151S).  In fact, the amount of cleaved product 
produced by GtgE(14-214) was similar to that of His-GtgE(2-228).  This result indicated that GtgE(14-
214) is active.  For GtgE(31-214), however, the 35 kDa band shows only a slight increase in intensity.  
In accordance with this observation, GtgE(31-214) exhibited much lower activity than that of His-
GtgE(2-228) and GtgE(14-214) (Fig. 3-10).  These results indicate that residues 14-30 are important 
for maintaining protease activity of GtgE.  
 
3.1.7 Mutation of the active site Cys45 
Despite extensive efforts and using several rescue strategies, I was not able to crystallize 
GtgE.  The rationale for these difficulties is likely the intrinsic flexibility of the N-terminal and 
C-terminal segments of GtgE.  Only removal of the first ~80 and the last 14 residues led to the 
crystallization of the remaining GtgE fragment.  In an attempt to reduce the flexibility of the 
protein, I proceeded with the co-crystallization of GtgE with the peptide corresponding to the 
Rab32 cleavage site.  Considering that GtgE is a protease, the cleavage reaction might occur 
quickly and the substrate might leave the active site after the reaction.  To avoid this, an inactive 
mutant of GtgE was used.  The nucleophile Cys45 was mutated to Ala or Ser, GST-GtgE(14-
214)(C45A) and GST-GtgE(14-214)(C45S), and these two mutants were transformed into the E. coli 
BL21 for expression.  GST-GtgE(14-214)(C45S) was soluble but GST-GtgE(14-214)(C45A) was 
insoluble.  GtgE(14-214)(C45S) was further purified using the method described for GtgE(14-214) 
(Fig. 3-11).  Purified GtgE(14-214)(C45S)  was mixed with the RATIGVDFALK peptide (Rab32 
cleavage site) and subjected to crystallization screening.  Unfortunately, no crystals were 
obtained by this method. 
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Fig. 3-10.  Determination of the protease activity of GtgE(14-214) and other construct using GST-
Rab32 as a substrate.  The reactions were conducted at room temperature.  Equal volume of the 
reaction mixture was loaded to each lane.  Lane 1: Cleavage of GST-Rab32 by GtgE(2-228)(H151S) 
in 2:1 (substrate : enzyme) in molar ratio after 2 h incubation, 2: Cleavage of GST-Rab32 by 
GtgE(2-228)(H151S) in 20:1 ratio after 2 h incubation , 3: protein markers, 4: Cleavage of GST-
Rab32 by His-GtgE(2-228) in 2:1 ratio after 1 h incubation, 5: Cleavage of GST-Rab32 by His-
GtgE(2-228) in 2:1 ratio after 2 h incubation, 6: Cleavage of GST-Rab32 by GtgE(14-214) in 2:1 ratio 
after 1 h incubation, 7: Cleavage of GST-Rab32 by GtgE(14-214) in 20:1 ratio after 1 h incubation, 
8: Cleavage of GST-Rab32 by GtgE(14-214) in 2:1 ratio after 2 h incubation, 9: Cleavage of GST-
Rab32 by GtgE(14-214) in 20:1 ratio after 2 h incubation, 10: Cleavage of GST-Rab32 by GtgE(31-
214) in 2:1 ratio after 1 h incubation, 11: Cleavage of GST-Rab32 by GtgE(31-214) in 20:1 ratio after 
1 h incubation, 12: Cleavage of GST-Rab32 by GtgE(31-214) in 2:1 ratio after 2 h incubation, 13: 
Cleavage of GST-Rab32 by GtgE(31-214) in 20:1 ratio after 2 h incubation, 14: protein markers.   
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Fig. 3-11.  Purification results for the GST-GtgE(14-214)(C45S).  A. SDS-PGAE gel showing 
fractions collected while purifying GST-GtgE(14-214)(C45S) on GSH resin.  Lane 1: protein 
markers, 2: supernatant, 3: proteins not retained on the resin, 4: protein retained to the resin.  B. 
SDS-PGAE gel showing the GST-tag cleavage result by TEV protease.  Lane 1: protein markers, 
2: protein not retained on the resin after cleavage, 3: proteins retained on the GSH resin after 
cleavage.  C. The elution profile of affinity purified GtgE(14-214)(C45S) from the Superdex 75 size 
exclusion column.  The insert shows the SDS-PAGE gel of fractions from the largest peak.   
 
3.1.8 Protease activity of GtgE(14-214)(C45S) 
The activity of GtgE(14-214)(C45S) mutants was tested by the same method as other 
constructs.  The reactions were set up at a substrate to enzyme ratio of 2:1 and 20:1 at room 
temperature for 1 h and 2 h.  From the SDS-PAGE, the cleavage product was not observed and 
the amount of the substrate was not decreasing.  The Cys45 mutation was therefore sufficient to 
inactivate GtgE (Fig. 3-12).   
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Fig. 3-12.  Determination of the protease activity of GtgE(14-214)(C45S) using GST-Rab32 as a 
substrate.  The reactions were conducted at room temperature.  Equal volume of the reaction 
mixture was loaded to each lane.  Lane 1: protein markers, 2: Cleavage of GST-Rab32 by His-
GtgE(2-228) in 2:1 ratio after 1 h incubation, 3: Cleavage of GST-Rab32 by His-GtgE(2-228) in 2:1 
ratio after 2 h incubation, 4: Cleavage of GST-Rab32 by GtgE(14-214)(C45S) in 2:1 ratio after 1 h 
incubation, 5: Cleavage of GST-Rab32 by GtgE(14-214)(C45S) in 2:1 ratio after 2 h incubation, 6: 
Cleavage of GST-Rab32 by GtgE(14-214)(C45S) in 20:1 ratio after 1 h incubation, 7: Cleavage of 
GST-Rab32 by GtgE(14-214)(C45S) in 20:1 ratio after 2 h incubation. 
 
3.1.9 1H-15N HSQC spectra of GtgE(14-214)(C45S) and the protein titration with peptide 
Nuclear magnetic resonance (NMR) is another common approach for determining protein 
structure (Wuthrich, 2001).  It is based on the principle that only isotopes containing an odd 
number of protons and/or neutrons have intrinsic magnetic moments in the magnetic field.  NMR 
active stable isotopes 13C and 15N are often introduced into the protein for NMR experiment.  The 
expression of 15N-labeled protein was obtained by growing the E. coli cell culture in minimal 
growth medium where the nitrogen source is fully 15N-labeled (Zhao et al., 2007).  The NH group 
is present in every amino acid residue with the exception of proline.  The 1H-15N HSQC 
(heteronuclear single quantum correlation) spectrum is used to record the interaction within NH 
group (Kwan et al., 2011).  In this spectrum we follow the 15N chemical shift along one axis and 
the 1H chemical shift along the second axis.  Since the chemical shifts are affected by the 
environment of the nuclei, the 1H-15N HSQC spectrum provides information about the folded 
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state of the protein.  Following a standard protocol for 15N labeling, GST-GtgE(14-214)(C45S) was 
expressed enriched in 15N.  15N-GtgE(14-214)(C45S) was purified by the same method as GtgE(14-
214) (Fig. 3-13).  The 1H-15N HSQC spectrum of 15N-GtgE(14-214)(C45S) was recorded on a 600 
MHz Bruker spectrometer by Mr. Corey Yu (Department of Biochemistry, University of 
Saskatchewan).  The protein solution was then titrated with the RATIGVDFALK peptide and the 
spectrum was recorded.  The two spectra were superimposed to visualize any differences.  The 
red spectrum represents GtgE and the blue shows GtgE titrated with a 5-fold molar excess of the 
peptide.  The HSQC spectrum of 15N-GtgE(14-214)(C45S) titrated with peptide was very similar to 
that of 15N-GtgE(14-214)(C45S) (Fig. 3-14).  This result indicates that there is, at most, only a weak 
interaction between 15N-GtgE(14-214)(C45S) and the peptide.   
 
Fig. 3-13.  Purification results for the GST-15N-GtgE(14-214)(C45S) construct.  A. SDS-PGAE gel 
showing fractions collected while purifying GST-GtgE(14-214)(C45S) on a GSH resin.  Lane 1: 
protein markers, 2: content of the protein pellets, 3: supernatant, 4: proteins not retained on the 
resin, 5: protein retained to the resin.  B. SDS-PGAE gel showing the GST-tag cleavage result by 
TEV protease.  Lane 1: protein markers, 2: protein not retained on the resin after cleavage, 3: 
proteins retained on the GSH resin after cleavage.  C. The elution profile of affinity purified 15N-
GtgE(14-214)(C45S) from the Superdex 75 size exclusion column.  The insert shows the SDS-
PAGE gel of fractions from the largest peak.   
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Fig. 3-14.  The HSQC spectra of 15N-GtgE(14-214)(C45S) and that titrated with the 
RATIGVDFALK peptide.  The spectrum of protein without peptide is in red and that of protein 
titrated with 5-fold excess of peptide is in blue.  The two spectra overlaid almost completely.  
Experiments performed by Mr. Corey Yu, Department of Biochemistry, University of 
Saskatchewan. 
 
3.1.10 Nanopore analysis as a potential method to identify unfolded termini in proteins  
A nanopore is a pore with an internal diameter of approximately 10 nanometers.  Many 
bacterial transmembrane proteins can be utilized as nanopores if they have an internal cavity 
crossing the entire membrane.  In particular, α-hemolysin is frequently used as a nanopore (Jetha 
et al., 2009).  Applying a voltage across the membrane results in an electrochemical gradient, 
which drives ions (including proteins and DNA) through the pore.  Depending on the properties 
of the molecule inserted into the pore, three kinds of events can be observed, 1) a translocation 
event, where the molecule passes through the pore; 2) an intercalation event, where the molecule 
became trapped in the entrance of the pore and 3) a bumping event, where the molecule 
approaches close to the pore blocking it temporarily but defuses away without entering (Meng et 
al., 2010). 
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To test if nanopore analysis could provide information about the order or disorder of the 
termini in proteins, I have subjected His-GtgE(2-228), GtgE(14-214) and GtgE(31-214) constructs to this 
analysis.  Indeed, each of the constructs exhibited unique behavior in these experiments.  His-
GtgE(2-228) showed 63% bumping events at -29 pA and 30% intercalation events at -63 pA (Fig. 
3-15.A).  GtgE(14-214) showed decreased bumping to 54% at -24 pA, and 35% intercalation events 
at -51 pA with an additional 5% translocation event peak at -80 pA (Fig. 3-15.B).  GtgE(31-214) 
showed a decreased bumping events to 27% relative to the GtgE(14-214) profile at -26 pA, and an 
increase intercalation events to 60% at -66 pA (Fig. 3-15.C).  Given that GtgE is a 25 kDa protein, 
the main factor affecting its translocation efficiency is its packing.  That is, a loosely packed 
structure will translocate more easily through the pore than one with tight packing.  The additional 
translocation peak from GtgE(14-214) indicates that the structure of GtgE(14-214) is less compact than 
His-GtgE(2-228) and GtgE(31-214).  Compared with His-GtgE(2-228), GtgE(31-214) showed a big 
decrease in bumping events, which indicates that GtgE(31-214) is less compact than the full length 
protein.   
 
 
 
Fig. 3-15.  Nanopore analysis of His-GtgE(2-228), GtgE(14-214) and GtgE(31-214) constructs.  All 
experiment was conducted with 100 mV voltage across the membrane.  Blockade current 
histograms for A. His-GtgE(2-228), B. GtgE(14-214), C. GtgE(31-214).  Experiment performed by Ms. 
Elisabet Jakova, Dr. Lee laboratory, Department of Biochemistry, University of Saskatchewan. 
 
3.1.11 Summary 
Despite extensive efforts I was unable to crystallize full length GtgE or its shorter 
constructs containing the entire catalytic triad (Cys45-His151-Asp169).  In addition to 
investigating multiple constructs, I have followed several rescue strategies that are commonly 
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applied to proteins that are difficult to crystallize.  One strategy relied on methylation of surface-
accessible lysines to change the surface properties of GtgE constructs.  Another approach, termed 
surface entropy reduction, relied on replacing a cluster of charged residues on the surface by 
alanines, thereby reducing the conformational freedom on the surface.  Finally, co-crystallization 
of GtgE(H151S) or GtgE(C45S) constructs with a peptide corresponding to the cleavage site of 
Rab32 were attempted.  Crystallization screening was performed at 20ºC and 4ºC because 
temperature is an important parameter in determining protein solubility.  Although I did not 
obtain crystals, I have learned much about cloning, protein expression, purification and 
characterization, as well as crystallization methods.  The quality of GtgE HSQC spectra suggests 
that more information about its three-dimensional structure could be obtained with NMR 
spectroscopy methodology.   
3.2 Structural studies of SpvB(26-355) 
3.2.1 Purification results for SpvB(26-355) 
Although the structure of the SpvB C-terminal, catalytic domain has been determined, 
neither the structure nor the function of its larger N-terminal domain is known.  The construct 
encompassing this domain includes residues 26 to 355.  This protein was expressed with an N-
terminal His-tag.  His-SpvB(26-355)  was expressed in the E. coli BL21(DE3)STAR cell line and 
purified in a manner similar to the His-tagged GtgE constructs (Fig. 3-16).   
3.2.2 SpvB crystallization, diffraction data collection and processing 
Crystallization screening of the SpvB-N with commercial and in-house screens did not 
produce crystals.  As a rescue strategy, the protein was methylated on surface-accessible lysine 
residues.  Continued screening of the methylated protein did eventually lead to the production of 
crystals.  The initial conditions were further optimized and the best conditions were established 
in the hanging drop format by mixing 1 µL of 27 mg/mL protein with 1 µL of reservoir solution 
containing 0.1 M Bis-Tris pH 6.5, 14% poly (acrylic acid) 5100 sodium, 4% PEG3350, 1 mM 
DTT and 20 mM MgCl2 (Fig. 3-17).  These crystals were grown at 15ºC   Diffraction data to 2.4 
Å resolution were collected at the Canadian Light Sources CMCF-ID beamline and processed 
with the program HKL3000 (Minor et al., 2006).  The diffraction data and refinement statistics 
are listed in Table 3-1.  
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Fig. 3-16.  Purification results for the His-SpvB(26-355) construct.  A. The elution profile of His-
SpvB(26-355) on the Ni-NTA.  The blue curve indicates the absorption at 280 nm and the orange 
curve indicates the elution imidazole gradient.  The column was washed with 1 M NaCl in 15 
mM HEPES pH 7.5 before subjected to imidazole elution.  The insert shows the SDS-PAGE gel 
of fraction from the peak.  B. Cleavage of the His tag from the construct by TEV protease.  Lane 
1: protein markers, 2: His-tagged protein. 3: untagged protein. 
 
 
 
Fig. 3-17.  Crystals of SpvB(26-355).  Crystals were obtained by the hanging drop method.  One 
microliter of the protein protein at 27 mg/mL was mixed with one microliter of reservoir solution 
containing 0.1 M Bis-Tris pH 6.5, 14% poly (acrylic acid) 5100 sodium, 4% PEG3350, 1 mM 
DTT and 20 mM MgCl2.  The crystallization plate was incubated at 15
oC. 
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Table 3-1.  SpvB(26-355) crystallographic data collection and processing statistics  
Diffraction data 
Diffraction source Canadian Light Sources CMCF-ID 
Wavelength (Å) 0.97949  
Temperature (K) 100 
Space group P43212 
Unit-cell parameters (Å)  101.4, 101.4, 211.3, 90, 90, 90 
No. of copies in the asymmetric unit  2  
Resolution range (Å) 50 - 2.4 (2.44 - 2.4) 
Total No. of reflections 646923 
No. of unique reflections 43823 (4131) 
Completeness (%) 99.52 (95.36) 
Redundancy 14.7 (14.1) 
I/σ(I) 26.62 (4.79) 
Rsyms
 0.074 (0.92) 
CC1/2 0.980 (0.920) 
Refinement 
Rwork/Rfree 0.200 / 0.239 
Mean B factor  
 Bond lengths 0.009  
 Bond angles 1.13 
Rsyms is defined as Rsyms= ∑| I - <I>|/∑I, where I = individual intensity measured and <I> = 
average intensity of the symmetry-related reflections.  CC1/2, the correlation coefficient, is 
another indicator of the quality of diffraction data (Karplus and Diederichs, 2012).  Values in 
parentheses are for the outer shell, 2.44-2.40 Å resolution.  
 
3.2.3 Structure determination and refinement 
The structure was solved by the molecular replacement method using residues 26-388 of 
YenB (PDB entry 4GIL) as a search model with the Phenix program suite (Adams et al., 2002).  
The refinement was performed using Phenix software and the manual rebuilding was done using 
the program Coot (Emsley et al., 2010a).  The crystal structure of SpvB(26-355) was determined at 
a resolution of 2.4 Å.  After refinement, the final values of Rwork and Rfree were 0.200 and 0.239 
respectively.  Each molecule contains only 2 lysine and the electron density shown that the lysines 
were monomethylated or dimethylated.   
The protein is elongated, with dimensions of 70 x 50 x 20 Å3 (Fig. 3-17).  The molecules 
interact within the crystal through the side surfaces, leaving both large faces accessible to the 
solvent (Fig. 3-18).  Each molecule contacts three other molecules.  The larger intermolecular 
contact area is ~700 Å2 while the other two contacts are smaller and comprise only ~300 Å2 (Fig. 
3-18).  These contact surfaces are rather small in comparison to the total surface area of SpvB(26-
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355) of ~14,500 Å2 and are in agreement with a monomeric form of SpvB(26-355) observed in 
solution.  The protein surface and contact surfaces were calculated using the PISA server 
(http://www.ebi.ac.uk/pdbe/pisa/).  
The structure of SpvB(26-355) consists of 21 β-strands and 3 short α-helices (Fig. 3-19).  
The β-strands are anti-parallel as indicated on the topology diagram (Fig. 3-20).  The secondary 
structure elements are displayed along the primary sequence, produced by the program PDBsum 
(https://www.ebi.ac.uk/thornton-srv/databases/cgi-bin/pdbsum/) (Laskowski, 2009) (Fig. 3-21).  
The crystal structure of SpvB(26-355) is relatively flat on one side, while there is a long and deep 
groove on the other side (Fig. 3-19).  The long groove on the structure of SpvB is also present in 
YenB.  This canyon in YenB participates in the formation of a central cavity that forms the path 
through which the cytotoxic domain of YenC passes to reach the host cell cytosol.  It is very 
likely that the groove in SpvB acts as a binding site for a target protein. 
 
 
 
Fig. 3-18.  Crystal contacts of SpvB(26-355).  There are two SpvB(26-355) molecules in the 
asymmetric unit (ASU).  Each molecule contacts three other molecules.  The larger contact area 
is ~700 Å2, calculated by Pisa sever (http://www.ebi.ac.uk/pdbe/pisa/).  The other contacts cover 
~300 Å2.  Each molecule is shown in a different color.  Molecules colored green and cyan are in 
an asymmetric unit, molecules colored grey and pink, yellow and purple, blue and orange are 
symmetry related to the former.   
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Fig. 3-19.  Structural of SpvB(26-355).  A. Cartoon representation of the protein. B. A view after 
rotating A 90° counter-clockwise.  C. The surface representation of the protein in the same view 
of B.  The yellow circle region indicates the groove in the protein surface.  Images were generated 
by Pymol Software (DeLano, 2002). 
 
 
 
 
Fig. 3-20.  Topology diagram of SpvB(26-355) generated in PDBsum server.  The β strands are anti-
paralleled.   
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Fig. 3-21.  The sequence of SpvB(26-355) with secondary-structure elements displayed above.  The 
diagram was generated by PDBsum.  There are 21 β-strands (labelled with B), colored in purple, 
and 3 short α-helices (labelled with A), colored in magenta in the structure.  The β-turns are 
represented by β, γ-turns by γ and β-hairpins by @.  The positions of the secondary structure 
elements are labelled according to the topology diagram.   
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3.3 Functional studies of SpvB(26-355) 
3.3.1 Interaction between SpvB and actin 
Considering that the C-terminal domain of SpvB ADP-ribosylates actin, the first 
hypothesis about the function of SpvB N-terminal region was that this domain binds actin to 
promote the ADP-ribosyltransferase activity.  To examine if the N-terminal domain binds actin 
in vivo, mammalian cells (HeLa or HEK293) were transfected with SpvB(1-591), SpvB(26-355), 
SpvB(26-591) or SpvB(390-591) constructs that were HA-tagged on the C-termini.  Once SpvB had 
been overexpressed, the host cells were harvested and lysed.  A co-immunoprecipitation (Co-IP) 
assay was performed using an anti-HA antibody and Protein G agarose resin.  On the Western 
blot, the anti-HA antibody was used to detect HA-tagged SpvB and anti-actin antibody was used 
to detect actin.  Actin was detected in all cell lysates, but not in the sample precipitated with anti-
HA antibody (Fig. 3-22).  The strong signal of SpvB-HA on the Western blot indicates that SpvB 
expressed and precipitated well in the host cells, but showed no significant binding to actin.  Lack 
of clear evidence for the interaction between SpvB and actin suggests that the interaction is either 
weak or transient.   
3.3.2 Localization of SpvB in the host cells 
Another formulated hypothesis was that the function of SpvB(26-355) was to guide the 
subcellular localization of the protein.  SpvB constructs, SpvB(1-591), SpvB(1-355) and SpvB(390-591) 
were fused at the C-terminus to GFP.  SpvB was expressed and the cells were subjected to 
immuno-fluorescent approaches.  Cells expressing SpvB(1-355)-GFP and the control cells 
expressing only GFP grew well, while cells expressing SpvB(1-591) and SpvB(390-591) detached 
from the glass slide and became round.  In the confocal fluorescent microscope, SpvB(1-355)-GFP 
showed a similar localization pattern to the GFP alone, which predominantly localized to the 
nucleus (Fig. 3-23).  Cells expressing SpvB(1-591)-GFP and SpvB(390-591)-GFP showed abnormal 
cell shape, nuclear fragmentation, and de-polymerization of F-actin (Fig. 3-23).  Due to changes 
in the cell caused by active SpvB(1-591)-GFP and SpvB(390-591)-GFP, it was not possible to reliably 
determine their localization.  Therefore, an inactivating mutation (EAE536AAA) was introduced 
at the active site of the C-terminal ART domain.  The localization of both mutants was clearly in 
the cytosol (Fig. 3-23).  These results indicate that the C-terminal domain directs the localization 
of SpvB to the cytosol to modify G-actin and to induce apoptosis.   
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Fig. 3-22. Co-immunonoprecipitation (Co-IP) of SpvB-HA constructs.  The upper panel shown 
the results for input using anti-actin antibody to detect actin.  The bottom panel shown the Co-IP 
result using anti-HA antibody and protein G agarose resin to precipitate SpvB.  The expression 
and precipitation of SpvB was detected by anti-HA antibody and actin was detected by anti-actin 
antibody.  No actin was detected in the precipitant.  Lane 1: HEK293 cell transfected with empty 
vector pCDNA4TO, 2: cells transfected with SpvB(1-591)-HA, 3: cells transfected with SpvB(26-
591)-HA, 4: cells transfected with SpvB(390-591)-HA, 5: cells transfected with SpvB(26-355)-HA.   
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Fig. 3-23.  Co-localization of SpvB and actin.  Cells were transfected with plasmids carrying 
SpvB-GFP constructs (indicated on the left of the images).  The green fluorescent light indicates 
the localization of GFP-tagged SpvB, the red fluorescent light stains F-actin filament and the blue 
fluorescent light shows the nuclei.  The yellow color results from the merger of red and green.   
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3.3.3 Detection of cytotoxicity of SpvB constructs with LDH assay 
Considering that the N-terminal domain of SpvB shows 47% sequence identity to YenB, 
another considered hypothesis was that SpvB(26-355) is cytotoxic and helps in host cell breakdown 
without directly interfering in actin dynamics.  A cytotoxicity assay was performed to test the 
cytotoxicity of SpvB constructs. A common method to measure protein cytotoxicity is to measure 
the levels of lactate dehydrogenase (LDH), which is upregulated and released when the cells are 
damaged.  HeLa cells expressing SpvB-GFP constructs were harvested and lysed.  The lysate 
was used to measure the amount of LDH present.  The LDH cytotoxicity results showed that the 
cells expressing SpvB(1-355)-GFP had 15% increase in cytotoxicity relative to the cells expressing 
only GFP.  SpvB(390-591)-GFP showed 43% increase in cytotoxicity compared to the GFP 
background and SpvB(1-591)-GFP presented a 2.3-fold increase in cytotoxicity (Fig. 3-24).  These 
results showed that by itself the N-terminal domain of SpvB had only marginal effect on 
cytotoxicity.   
 
 
Fig. 3-24.  Cytotoxicity measuring by lactate dehydrogenase (LDH).  HeLa cells were transfected 
with empty vector pEGFP-N1 and spvB constructs.  Values of cytotoxicity are the means of three 
independent determinations.  P value were determined by Student’s test, compared with the cell 
only overexpressing GFP.  ** indicates p<0.01.  
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3.3.4 Secretion of SpvB-Flag in Salmonella strains 
In order to test the secretion of SpvB in Salmonella, the Flag tag was fused to the C-
terminus of SpvB(1-591) and this construct was expressed in Salmonella under several conditions: 
(1) in LB medium; (2) in LB supplemented with 0.3M NaCl to stimulate SPI-1 TTSS and (3) in 
low pH medium that stimulated the SPI-2 TTSS.  After expression of SpvB(1-591)-Flag, cells were 
spun down and the supernatant was analyzed by Western blot to detect SpvB(1-591)-Flag.  To detect 
possible cell leakage, the presence of a cytosolic DnaK chaperon was followed by anti-DnaK 
antibody.  Anti-SopE2 serum was used to follow SopE2 (a known SPI-1 substrate), and anti-SseL 
serum followed anti-SseL (a known SPI-2 substrate).  
It was found that SpvB(1-591)-Flag and SopE, but not SseL were present in the supernatant 
from wild-type Salmonella grown in a SPI-1 stimulating condition (Fig. 3-25).  However, DnaK 
was also detected, indicating some level of cell disruption.  Therefore, it was not clear if SpvB 
was indeed secreted through SPI-1 TTSS.  The same leakage problem occurred when bacteria 
were grown in the LB medium.  When bacteria were grown in the SPI-2 stimulating condition, 
no DnaK was detected in the media.  As expected, SseL was detected in the media, indicating 
that the SPI-2 TTSS was indeed functional (Fig. 3-25).  However, no SpvB(1-591)-Flag was 
detected in the supernatant, implying that this protein is not secreted by the SPI-2 TTSS.   
The secretion assay was also done in Salmonella strains defective in secretion systems.  
Salmonella Δspi-1 strain was grown in a SPI-2 stimulating condition, Δspi-2 strain in a SPI-1 
stimulating condition, and Δspi-1&2 strains in LB medium.  DnaK was present in the supernatant 
arising from bacteria grown in LB and SPI-1 stimulating media, but not in the SPI-2 stimulating 
medium.  SseL was also detected in the supernatant of SPI-2 stimulating medium, but SpvB was 
not (Fig. 3-26).  In conclusion, the secretion of SpvB though a functional SPI-2 TTSS was not 
observed.  These results disagree with the previously published data showing secretion of SpvB 
by Δspi-1 mutant strain (ΔinvA) and Δspi-2 mutant strain (ΔssrA) (Gotoh et al., 2003). 
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Fig. 3-25.  Secretion of SpvB in the wild-type Salmonella strain.  A. Western blot result when 
detecting with anti-Flag and anti-SopE2 antibodies.  B. Western blot result when detecting with 
anti-DnaK and Anti-SseL antibodies.  The primary antibodies used for detecting desired proteins 
were labelled on the left side of the Western blot.  Samples loaded on A and B were identical.  
Protein markers was used on the left side on the first blot and in the middle on the second bolt.  
Lane 1: cell pellet of the starting overnight culture, 2: cell pellet grown in LB medium, 3: cell 
pellet grown in SPI-1 condition, 4: cell pellet grown in SPI-2 condition before IPTG induction, 
5: cell pellet grown in SPI-2 condition after IPTG induction, 6: protein precipitated from the cell 
supernatant grown in LB medium, 7: protein precipitated from the cell supernatant grown in SPI-
1 medium, 8: protein precipitated from the cell supernatant grown in SPI-2 medium. 
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Fig. 3-26.  Secretion of SpvB in the wild-type and mutant Salmonella strains.  A. Western blot 
result when detecting with anti-Flag and anti-SopE2 antibodies.  B. Western blot result when 
detecting with anti-DnaK and Anti-SseL antibodies.  The primary antibodies used for detecting 
desired proteins were labelled on the left side of the Western blot.  Samples loaded on A and B 
were identical.  Protein markers was used on the left side on the first blot and in the middle on 
the second bolt.  Lane 1: protein control (SopE2 in A and SseL in B), 2: cell pellet of wild-type 
strain, 3: cell pellet of Δspi-1strain, 4: cell pellet of Δspi-2strain, 5: cell pellet of Δspi-1&2 strain, 
6: protein precipitated from supernatant of wild-type strain, 7: protein precipitated from 
supernatant of Δspi-1strain, 8: protein precipitated from supernatant of Δspi-2 strain, 9: protein 
precipitated from supernatant of Δspi-1&2 strain. 
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4. Discussion 
4.1 GtgE and Rab32 
4.1.1 GtgE displays very low activity in vitro against GST-Rab32 
GtgE is an effector present in S. Typhimurium strains but absent in S. Typhi strains.  S. 
Typhimurium has a broad range of hosts, while S. Typhi is human-specific (Spanò and Galán, 
2012).  Expression of GtgE in S. Typhi helped this bacterium to overcome the host-specificity 
restriction as this engineered strain was able to invade mouse macrophages (Spanò and Galán, 
2012).  GtgE was identified as a cysteine protease that specifically cleaves Rab29, Rab32 and 
Rab38 but not other Rab proteins (Spanò and Galán, 2012).   
To confirm the activity of recombinant GtgE toward Rab32, SDS-PAGE based analysis 
was performed.  The cleavage results showed indeed a low level of GtgE(2-228) protease activity 
based on the appearance of a new lower molecular weight bands not observed in the control.  
However, Rab32 was only partially cleaved even after 2 h incubation with 1:2 molar ratio of 
GtgE:Rab32.  The low protease activity of GtgE in vitro might be due to the extensive flexibility 
of the N-terminal segment of GtgE containing the active site Cys45.  It was found that Rab29, 
the GtgE substrate, was recruited on the membrane of SCV of S. Typhi but not on the membrane 
of SCV of S. Typhimurium (Spano et al., 2011).  This indicates that GtgE is secreted to cleave 
Rabs near the SCV surface.  The presence of a membrane or a protein anchored to the membrane 
might be a factor in the correct folding of GtgE.   
GtgE truncations were also used to test their cleavage activity.  It was found that the 
truncation construct GtgE(14-214) was still active, however GtgE(31-214) lost activity almost 
completely.  This suggests that the N-terminal region is essential for the GtgE activity and the 
first 30 residues are needed to stabilize the GtgE active site.   
GtgE constructs were efficiently expressed and purified.  As indicated by dynamic light 
scattering, molecules in solution were monodispersed, which was promising for successful 
crystallization.  However, despite screening several hundred crystallization conditions for each 
construct, no crystals were obtained for any of the investigated constructs.  Unfortunately, the 
standard crystallization rescue strategies, such as chemical modification of surface accessible 
lysines or surface entropy reducing mutations, were not helpful in crystallizing this protein.  
Similarly, co-crystallization screening of a GtgE active site mutants with peptide substrate did 
not produce crystals.  I conclude that the failure to crystallize GtgE stems from the 
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flexibility/disorder of its N-terminal ~80 residues.  Indeed, limited proteolysis of GtgE(43-214) 
(Kohler et al., 2014) showed the presence of a smaller 17 kDa fragment, which was identified by 
mass spectrometry as GtgE(79-214).  The GtgE(79-214) was further degraded into a smaller fragment 
at 15 kDa, which was identified as GtgE(79-200) (Kohler et al., 2014).  Thus, the N-terminal first 
~80 residues and the C-terminal ~28 residues are partially disordered.  The fragment GtgE(79-214) 
was crystallized and its structure solved (Kohler et al., 2014).  
I have also used an NMR approach in this project to determine the structure of 
GtgE(14-214)(C45S).  The HSQC spectrum was used to evaluate the state of GtgE.  In the well-
ordered protein, the environment of individual NH group differs, leading to a wide distribution 
of the NH signals in the spectrum.  The NH groups within the flexible regions are exposed to 
multiple environments, which average to a much more similar effect on their chemical shift and 
a narrower distribution of peaks in the spectrum.  While the NH signals for GtgE were well 
dispersed, they were present for only ~75% of residues.  The titration of GtgE(14-214)(C45S) with 
a 5-fold excess of RATIGVDFLAK peptide introduced almost no changes in the spectrum.  Such 
lack of changes indicates that there is at most only very weak binding of the peptide to GtgE.  
This could mean that the GtgE recognizes some three dimensional features of the substrate 
outside of the linear peptide containing the cleavage site.   
4.1.2 N-terminal region makes GtgE unstable 
The GtgE constructs behaved differently in nanopore analysis.  From the histogram of 
current blockade, GtgE(14-214) showed less bumping events and had an additional translocation 
peak when compared with the profile with His-GtgE(2-228).  This result indicates that the regions 
at the N- and C-termini affect the conformation of the protein.  Since more bumping events were 
found in His-GtgE(2-228), it was likely that the N-terminal region interacts with the C-terminal 
region to make the protein more compact and reduces the conformational flexibility of the termini.  
Compared with GtgE(14-214), GtgE(31-214)  was involved in fewer bumping events, more 
intercalation events but showed no translocation events.  This suggests that GtgE(14-214) is less 
compact than GtgE(31-214) with the N-terminal segment being disordered.  It is likely that the first 
14 N terminal residues makes GtgE unstable.   
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4.1.3 Conclusion and perspectives 
The purified GtgE showed low activity in vitro with its substrate.  The possibility that the 
activity is stimulated by the presence of a membrane was investigated by following the reaction 
in the presence of lipid vesicles, however no increase in the activity was evident.  This low 
protease activity in vitro (as well as lack of success in GtgE crystallization) is likely related to 
the flexibility of the protein, particularly of its first ~80 residues which contain the nucleophilic 
Cys45 of the catalytic triad.  Further research will be required to study why GtgE shows low 
enzyme activity and what are the structural determinants of its substrate specificity.   
4.2 SpvB and actin  
4.2.1 Structure determination of the N-terminal domain of SpvB 
SpvB is an essential effector for the virulence of Salmonella.  It is known that the C-
terminal domain of SpvB ADP-ribosylates actin and the modification results in a degradation of 
actin cytoskeleton (Margarit et al., 2006).  The structure and function of the N-terminal domain 
was unknown.  In this project, the structure of SpvB(26-355) was determined at 2.4 Å resolution. 
Based on size exclusion chromatography and dynamic light scattering SpvB(26-355) was present in 
solution as a monomer.  Although there are two molecules of SpvB(26-355) in the asymmetric unit 
of the crystal (P43212 space group), the analysis of contacts in the crystal supports the notion that 
SpvB-N is monomeric.   
4.2.2 Co-immunoprecipitation assay excluded strong interaction between SpvB and actin 
The groove present on the surface of SpvB(26-355) suggests that the function of this domain 
might involve binding another moiety and the extent of the groove points toward an extended 
peptide moiety as a possible target.  Considering that the C-terminal domain of SpvB modifies 
actin, it seemed plausible that the N-terminal domain of SpvB binds to actin to aid in the function 
of the C-terminal domain.  The co-IP assay was performed to detect the interaction between 
various SpvB fragments (SpvB(26-355)-HA, SpvB(390-591)-HA, SpvB(26-591)-HA and SpvB(1-591)-HA) 
and actin.  However, actin was not detected after precipitating SpvB constructs.  It is known that 
the C-terminal domain of SpvB is able to modify actin and prevents the polymerization of actin 
in vitro (Margarit et al., 2006).  This indicates that the C-terminal domain of SpvB has to contact 
actin.  Since actin was not detected in the co-IP experiment, it was likely that the interaction 
between C-terminal domain of SpvB and actin was transient.  This does not support the 
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hypothesis that the N-terminal of SpvB binds actin to promote the activity of the C-terminal 
domain.   
4.2.3 SpvB(390-591) is sufficient to disrupt the host cytoskeleton and induce cell apoptosis 
To validate the function of SpvB domains in causing the observed cell phenotype, SpvB 
constructs (SpvB(1-355)-GFP, SpvB(390-591)-GFP and SpvB(1-591)-GFP) were transfected into HeLa 
cells.  The expression of SpvB(1-591)-GFP or SpvB(390-591)-GFP caused cell deformation and 
detachment from the cover slides where the cells were plated, while no obvious phenotype was 
found when cells overexpressed SpvB(1-355)-GFP.  It is known that the expression of SpvB results 
in degradation of the actin cytoskeleton and induces cell cycle arrest and apoptosis (Paesold et 
al., 2002; Mesa-Pereira et al., 2013).  Our transfections with truncated constructs showed that the 
C-terminal domain of SpvB led to the same phenotype as the full length SpvB.   
Since expression of the full length SpvB as well as the C-terminal domain alone caused 
cell death, it was not possible to determine localization of these SpvB constructs.  Therefore the 
active site mutation EAE536AAA was introduced in SpvB(390-591)-GFP and SpvB(1-591)-GFP to 
inactivate SpvB ADP-ribosyltransferase activity.  These plasmids were used to transfect HeLa 
cells.  The immunofluorescent assay to detect localization of the SpvB constructs showed that 
the N-terminal domain of SpvB predominantly localized to the nucleus in the same fashion as 
GFP alone expressed from the empty vector (control), while SpvB(390-591)(EAE536AAA)-GFP 
and SpvB(1-591)(EAE536AAA)-GFP were predominantly localized to the cytosol.  The different 
localization of the SpvB(1-355) from the other two constructs indicated that the C-terminal domain 
of SpvB played a dominant role in SpvB localization to the cytosol in order to access and modify 
G-actin.  The N-terminal domain of SpvB seems to play no role in the localization of SpvB in the 
host cells.  In conclusion, the C-terminal domain was sufficient to cause cell deformation and 
detachment by directing the localization of SpvB to the cytosol and by modifying actin to 
interfere with actin cytoskeleton dynamics.   
4.2.4 SpvB(1-355) has a marginal effect on the cytotoxicity inside the host cells 
To test the function of SpvB(1-355) inside the host cells, a cytotoxicity assay was performed.  
HeLa cells were transfected with SpvB constructs and their cytotoxicity was evaluated by 
measuring LDH activity.  Cells expressing SpvB(1-355)-GFP had only 15% increasing compared 
with the levels of LDH in cells expressing only GFP.  This indicated that SpvB(1-355) had a small 
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cytotoxic effect.  Cells expressing SpvB(390-591)-GFP showed a 43% increase in cytotoxicity and 
a 2.3-fold increase in cytotoxicity was observed for cells expressing SpvB(1-591)-GFP.  The effect 
of SpvB(1-591) was more than the sum of effects caused by the N-terminal and the C-terminal 
domains.  This result suggests that these two domains of SpvB cooperate to some extent in 
inducing cytotoxicity.  
4.2.5 SpvB appears not to be secreted through SPI-2 TTSS 
The C-terminal domain of SpvB was sufficient to cause the abnormal phenotype and to 
modify actin, indicating that the N-terminal region of SpvB may have no function inside the host 
cells but rather in the bacterial cell.  Considering that SpvB is an effector, the secretion path can 
be divided into three stages: from the ribosome to the secretion systems, from the secretion 
systems to the host cytosol and inside the host cytosol.  Although the N-terminal domain of SpvB 
is homologous to the N-terminal region of TcB, absence of the rest of the toxin apparatus makes 
SpvB secreted in a different way to Tc toxin.  It is therefore possible that the N-terminal domain 
of SpvB plays a role in secretion of SpvB.   
The SpvB-Flag was expressed in Salmonella wild-type and mutant strains and the 
secretion assay was performed to detect the secretion of SpvB.  No SpvB secretion was observed 
under the condition stimulating SPI-2 TTSS.  SpvB is less likely secreted through SPI-1 TTSS, 
although our experiment was not conclusive due the cell leakage problem under SPI-1 stimulating 
conditions.  However, it is known that the expression of SpvB is upregulated in the late 
endocytosis stage, while SPI-1 TTSS is downregulated as the bacterium resides in the SCV 
(Schlumberger and Hardt, 2006).  On the time axis, the maximum expression of SpvB and the 
activity of the SPI-1 TTSS do not coincide, supporting the hypothesis that the secretion of SpvB 
may be independent of TTSS.  Indeed, although we have seen SpvB in the medium in the SPI-1 
stimulating condition, which could likely be attributed to the observed cell leakage, we did not 
see secretion of SpvB under SPI-2 stimulating condition, in agreement with Gotoh et al. (Gotoh 
et al., 2003).   
4.2.6 Conclusions and perspectives 
In conclusion, the C-terminal domain of SpvB was sufficient to cause the abnormal host 
cell phenotype, while the function of the N-terminal domain of SpvB was most likely associated 
with the events inside the bacterial cell leading to SpvB secretion.  The secretion assay indicated 
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that SpvB was likely not secreted through SPI-2 TTSS.  Therefore, how SpvB is secreted remains 
an open question.  Further experiments will be required to find out the secretion path of SpvB.   
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